Join Communities

Search Notes Gallery

Home / notes / Pharmaceutical Inorganic and Analytical Chemistry Unit 4 Notes – Gastrointestinal Agents, Antimicrobials and Radiopharmaceuticals

Pharmaceutical Inorganic and Analytical Chemistry Unit 4 Notes – Gastrointestinal Agents, Antimicrobials and Radiopharmaceuticals

NotesGallery
Nov 20, 2026 • 85 min read
Pharmaceutical Inorganic And Analytical Chemistry Source: NotesGallery

Course Code: BP106T

Unit IV Introduction

Gastrointestinal agents, antimicrobials and radiopharmaceuticals connect inorganic chemistry with medicinal action, analytical quality and safe handling. This unit explains how acid-base reactions, osmotic water retention, oxidation, halogen chemistry, biological distribution and radioactive decay produce different pharmaceutical effects.

Pharmaceutical Inorganic and Analytical Chemistry Unit 4 Notes begin with acidifiers and antacids. Sodium acid phosphate and dilute hydrochloric acid illustrate acidification, whereas sodium bicarbonate and aluminium hydroxide gel illustrate neutralization. Magnesium hydroxide, sodium phosphate salts and sodium potassium tartrate connect salt chemistry with osmotic bowel action. Magnesium trisilicate requires particular care because its principal role is as an antacid and its hydrated composition is variable.

The antimicrobial sections distinguish antisepsis, disinfection and sterilization. Potassium permanganate, boric acid, hydrogen peroxide, chlorinated lime and iodine preparations differ in reactive species, activity, formulation and limitations. Their assays demonstrate why an oxidizing medicinal agent can act as a reducing substance against a stronger analytical oxidant, and why total halogen content differs from available oxidizing content.

The radiopharmaceutical sections introduce nuclear notation, emissions, activity, physical half-life, biological elimination and effective half-life. Iodine-131, technetium-99m, cobalt-60 and phosphorus-32 illustrate how emission characteristics and chemical form determine medical applications. Quality control also requires separate consideration of radionuclidic, radiochemical and chemical purity.

Balanced reactions explain assays and theoretical properties, but physical form and formulation remain important. A wet gel is not a mass of pure dry hydroxide. A powder with unchanged appearance can lose available chlorine. A clear radiopharmaceutical can contain an unwanted chemical form. A radioactive activity value without a calibration time is incomplete.

Topics Covered – Complete Syllabus Map

Required topic Notes sections
Gastrointestinal principles and acidifiers 1–2
Ideal antacids and combination rationale 3
Sodium bicarbonate 4
Aluminium hydroxide gel 5
Bowel agents and gastrointestinal comparisons 6–7
Antimicrobial mechanisms and classes 8
Potassium permanganate and boric acid 9–10
Hydrogen peroxide 11
Chlorinated lime 12
Iodine and its preparations 13
Radioactivity and half-lives 14–15
I-131, Tc-99m, Co-60 and P-32 16–18
Handling, monitoring, storage, disposal and safety 19–20
Integrated calculations and examination revision 21

Learning outcomes

  • Explain acidifier, antacid and bowel-agent mechanisms.
  • Compare ideal antacid properties and combination rationale.
  • Describe preparation, properties, assay principles, uses and storage of the prescribed compounds.
  • Distinguish antisepsis, disinfection and sterilization.
  • Explain oxidizing, chlorine-releasing and iodine preparations.
  • Calculate assay content, available chlorine and peroxide volume strength.
  • Interpret activity, emissions and physical, biological and effective half-lives.
  • Compare the four prescribed medical radioisotopes.
  • Explain suitable monitoring, shielding and authorized waste control.

Essential vocabulary

Term Meaning
Acidifier Agent increasing acidity in a specified system
Antacid Agent neutralizing existing gastric acid
ANC Acid-neutralizing capacity under defined conditions
Osmotic laxative Agent retaining water in the intestinal lumen
Antiseptic Antimicrobial intended for suitable living tissue
Disinfectant Antimicrobial intended for suitable inanimate materials
Available chlorine Oxidizing capacity expressed as Cl₂ equivalent
Radionuclide Unstable nuclide undergoing nuclear decay
Activity Rate of radioactive disintegration
Half-life Time for the specified quantity to halve
ALARA Exposure kept as low as reasonably achievable

Central question: How do chemical reactions, biological distribution and radioactive decay determine medicinal action, quality testing and safe handling?

1. Gastrointestinal agents: foundation

The gastrointestinal tract receives food, secretes digestive fluids, absorbs nutrients and eliminates residue. Inorganic agents act mainly through acid-base reactions, osmotic effects or local protective action. Their usefulness depends on the chemical form, amount, formulation and site of action.

Gastric acid and pharmaceutical action

Parietal cells secrete hydrochloric acid into the stomach lumen. The acidic environment supports protein digestion and limits survival of many ingested organisms. The mucus-bicarbonate barrier protects the gastric surface; acid can damage tissue when protective mechanisms are impaired.

Acidifiers supply acidity when indicated. Antacids neutralize acid already present; they do not directly switch off acid secretion. Saline laxatives retain water in the intestinal lumen and promote bowel evacuation. Antimicrobials reduce susceptible organisms through specific chemical injury.

Gastric regions and mucosal folds explain the location of acid and local antacid action.

Diagram labels: Stomach: anatomical cut-section; Oesophagus; Fundus; Duodenum; Pyloric sphincter; Rugae; Greater curvature; Lesser curvature; Anterior wall opened to show mucosal folds.

Group Primary chemical action
Acidifier Provides H⁺ or an acidic salt
Antacid Consumes gastric H⁺
Saline laxative Retains luminal water osmotically
Antimicrobial Oxidizes, halogenates or otherwise damages microbial components

How to study each compound

Identify its formula and hydrate form, preparation, properties, mechanism, assay principle, uses and storage. Distinguish a theoretical reaction from the behaviour of a formulated medicine. A suspension can act effectively even when the solid is only sparingly soluble.

Three different objectives

Adding acid, neutralizing acid and retaining intestinal water are different actions. Do not classify every gastrointestinal salt as an antacid.

2. Acidifiers

Acidifiers increase acidity in a specified compartment or preparation. Gastric acidifiers historically supplement inadequate gastric acidity; urinary or systemic acidification involves different physiological mechanisms. The syllabus compounds must be described according to their actual chemical properties.

2.1 Sodium acid phosphate

Sodium acid phosphate is sodium dihydrogen phosphate, NaH₂PO₄; it is also called monobasic sodium phosphate. The anhydrous molar mass is about 119.98 g/mol. Hydrated forms have different formula masses, so the exact form must be stated in calculations.

It occurs as colourless crystals or a white crystalline material, dissolves in water and gives an acidic solution. H₂PO₄⁻ can donate a proton to form HPO₄²⁻, but it can also accept a proton; its predominant behaviour depends on the medium.

H₂PO₄⁻ + H₂O ⇌ HPO₄²⁻ + H₃O⁺

Preparation and pharmaceutical significance

Controlled partial neutralization of phosphoric acid gives the monobasic salt:

H₃PO₄ + NaOH → NaH₂PO₄ + H₂O

Concentrating and crystallizing the solution produces the selected hydrate under controlled conditions. Excess alkali changes the product to a more highly neutralized phosphate.

It is used as an acidifying and buffering ingredient. Sodium phosphate preparations may also act as saline laxatives; that action depends on their formulation and should not be confused with gastric acid supplementation.

Quality and storage

Identity relies on sodium and phosphate reactions. Assay can use suitable acid-base titration with a defined endpoint or another validated phosphate method. Control the hydrate basis, moisture and contaminating ions. Store in a well-closed container appropriate to the specified form.

2.2 Dilute Hydrochloric acid

Dilute Hydrochloric acid is an aqueous preparation of HCl of specified strength. The molar mass of HCl is 36.46 g/mol; the medicine is a solution, not solid molecular HCl. It is clear and colourless, strongly acidic, and miscible with water.

HCl + H₂O → H₃O⁺ + Cl⁻

Preparation involves controlled dilution of a stronger acid using suitable water. Add acid slowly to water with mixing and cooling, because dilution releases heat. The target concentration must come from the intended specification rather than an assumed universal percentage.

Assay and uses

Neutralization with standardized sodium hydroxide measures the acid content:

HCl + NaOH → NaCl + H₂O

A suitable indicator or potentiometric endpoint detects neutralization. Each mL of 0.100 M NaOH corresponds to 3.646 mg HCl. Dilution factors and any blank correction must be included.

Dilute HCl is a historical gastric acidifier for selected cases of inadequate acidity and a pharmaceutical pH-adjusting reagent. Clinical use requires a formulated, prescribed preparation; concentrated acid is corrosive. Store in a tightly closed, compatible container, separated from incompatible bases and reactive materials.

Feature Sodium acid phosphate Dilute HCl
Chemical type Acidic phosphate salt Strong-acid solution
Source of acidity Phosphate equilibrium Extensive HCl ionization
Additional role Buffer component Direct pH adjustment
Calculation basis Specified salt and hydrate Actual HCl solution strength

3. Antacids: Ideal Properties and Combinations

Antacids react with hydrochloric acid in the stomach and reduce acidity. Raising pH can reduce acid-mediated irritation and pepsin activity, but neutralization does not establish that the cause of disease has been treated.

3.1 Ideal properties

  • Neutralize an appropriate amount of acid promptly and maintain useful action without excessive alkalinization.

  • Remain largely local and minimize absorbed alkali or electrolyte loads.

  • Avoid troublesome gas production, constipation or diarrhoea.

  • Be palatable, stable, affordable and easy to disperse or administer.

  • Have predictable acid-neutralizing capacity, controlled impurities and reliable batch quality.

  • Minimize interference with nutrient and medicine absorption. No single agent meets every ideal requirement. Solubility, surface area, gastric residence time and formulation affect the rate and duration of action.

3.2 Classification and neutralizing capacity

Absorbable antacids, such as sodium bicarbonate, can introduce a systemic alkali and sodium load. Poorly absorbed antacids, such as aluminium hydroxide, mainly act locally, although relevant absorption and accumulation can still occur in susceptible patients.

Acid-neutralizing capacity (ANC) is commonly expressed as mEq of acid neutralized under defined test conditions. A balanced equation gives theoretical capacity, whereas an experimental test also reflects dissolution, reaction rate and the chosen endpoint.

Al(OH)₃ + 3HCl → AlCl₃ + 3H₂O

One mmol of pure Al(OH)₃ can theoretically neutralize 3 mEq H⁺. One mmol of NaHCO₃ neutralizes 1 mEq H⁺. Equal milligram quantities are therefore not interchangeable.

3.3 Why combine antacids?

Aluminium salts tend to cause constipation; magnesium salts tend to loosen stools. Combinations can balance these effects and combine differing reaction rates and capacities. The balance is not guaranteed for every patient or every ratio.

Combination principle Purpose and limitation
Aluminium + magnesium May balance constipation and laxation
Different reaction rates Can support rapid and more sustained neutralization
Suspension formulation Disperses particles for contact with gastric acid
Optional antiflatulent ingredient Addresses gas symptoms; does not itself determine ANC

Interactions include altered gastric pH and binding or complexation of other medicines. Such interactions depend on the medicine and timing; no single separation interval applies universally. Magnesium, aluminium, phosphate and sodium loads require particular consideration in renal impairment.

Exam distinction

An antacid combination is designed around complementary properties. It is not an automatic guarantee of greater efficacy or absence of adverse effects.

4. Sodium bicarbonate

Formula: NaHCO₃. Molar mass: 84.01 g/mol. Synonyms: sodium hydrogen carbonate; baking soda. It is a white crystalline powder, soluble in water, with a mildly alkaline aqueous solution.

Preparation

Carbon dioxide is passed into a suitable sodium carbonate solution. Conditions favouring bicarbonate formation and crystallization are controlled; the crystals are separated and dried without excessive heating.

Na₂CO₃ + CO₂ + H₂O → 2NaHCO₃ Industrial manufacture may use the ammonia-soda process, but pharmaceutical material must meet its own purity requirements. Strong heating decomposes bicarbonate:

2NaHCO₃ → Na₂CO₃ + CO₂ + H₂O

Antacid action and identification

NaHCO₃ + HCl → NaCl + CO₂↑ + H₂O

This rapid reaction explains its antacid action and effervescence. Evolved carbon dioxide may cause belching and gastric distension. Absorbed bicarbonate can contribute to systemic alkalosis, and sodium increases the electrolyte load.

Carbon dioxide evolution accompanies bicarbonate neutralization of hydrochloric acid.

Diagram labels: Bicarbonate consumes acid and releases CO₂; NaHCO₃ + dilute acid; CO₂ bubbles; Aqueous NaCl; NaHCO₃ + HCl → NaCl + CO₂ + H₂O.

Identity includes sodium reactions and liberation of carbon dioxide on adding acid. The gas can turn limewater milky through calcium carbonate formation. Water solubility and alkalinity help characterize the material but do not replace identity tests.

Assay: direct acidimetry

Dissolve an accurately weighed sample in water and titrate with standardized HCl using methyl orange in a specified acidimetric procedure. Near the endpoint, ensure adequate mixing and handle dissolved carbon dioxide as required by the validated method.

HCO₃⁻ + H⁺ → CO₂ + H₂O

Stoichiometry is 1 mol bicarbonate to 1 mol HCl. The reagent factor is:

1 mL of 0.200 M HCl ≡ 16.802 mg NaHCO₃.

For 0.100 M HCl, the factor is 8.401 mg/mL. Do not use a sodium carbonate factor, which involves two acid equivalents per mole at complete neutralization.

Worked assay

A 0.5000 g sample consumes 29.40 mL of 0.2000 M HCl; assume no dilution or blank correction.

Mass found = 29.40 × 16.802 = 493.98 mg.

Purity = (493.98 / 500.0) × 100 = 98.80%.

If only an aliquot is titrated, multiply the found mass by the total-volume/aliquot-volume ratio before calculating the percentage of the original sample.

Uses, quality and storage

Uses include antacid action, selected alkalinizing applications and effervescent formulations. It is also a reagent and formulation pH modifier. Excessive use may cause alkalosis and sodium-related problems; these are chemical reasons to prefer appropriate formulated use.

Quality control includes identity, assay and specified tests for carbonate, chloride, sulphate, ammonium and other impurities as applicable. Keep well closed and protected from moisture and excessive heat. Moisture can initiate reactions with acidic ingredients in effervescent mixtures.

5. Aluminium hydroxide gel

Aluminium hydroxide gel is an aqueous suspension of hydrated, amorphous aluminium hydroxide; limited carbonate substitution may be present. Al(OH)₃ is a useful chemical representation, with a formula mass of about 78.00 g/mol, but a wet gel contains substantial water and is not a weighed mass of pure anhydrous Al(OH)₃.

Physical and chemical properties

It is a white, viscous dispersion with particles that are practically insoluble in water. Aluminium hydroxide is amphoteric: it dissolves in acid and can dissolve in sufficiently strong alkali as aluminate. Amphoterism does not mean that the gel is acidic in the stomach; it consumes gastric acid.

Al(OH)₃ + 3H⁺ → Al³⁺ + 3H₂O

Al(OH)₃ + OH⁻ → [Al(OH)₄]⁻

Preparation and processing

One route precipitates hydrated hydroxide by adding an aluminium salt solution to controlled alkaline conditions. Sodium carbonate can be used; the precipitate is washed to remove soluble salts and dispersed in suitable water to obtain the required gel strength.

2AlCl₃ + 3Na₂CO₃ + 3H₂O → 2Al(OH)₃↓ + 6NaCl + 3CO₂↑

Alum-based routes are also used. The order of addition, pH and temperature affect particle properties and retained impurities. Avoid excess alkali that can redissolve the hydroxide. The equation describes a chemical route, not a complete manufacturing specification.

Controlled precipitation, washing and redispersion produce hydrated aluminium hydroxide gel.

Diagram labels: Hydroxide precipitation and gel preparation; Aluminium salt solution; Carbonate solution; Hydrated Al(OH)₃; Wash and redisperse; Gel.

Drying produces dried aluminium hydroxide gel, which has a different water content and must be tested on its own specified basis. Excessive drying or ageing can alter reactivity; wet and dried products are not equivalent gram for gram.

Antacid action and limitations

The gel neutralizes acid relatively slowly, without the carbon dioxide evolution characteristic of bicarbonate. Constipation is a common limitation. Aluminium can bind phosphate, and prolonged inappropriate exposure may disturb phosphate balance. Accumulation becomes particularly relevant in impaired renal function.

Assay: EDTA back-titration

Dissolve a measured sample in acid, dilute and take a defined aliquot. Add a known excess of standardized disodium edetate. Adjust conditions and warm on a water bath to allow aluminium complexation to proceed sufficiently; it can be slow at room temperature.

Al³⁺ + Y⁴⁻ → AlY⁻

Back-titrate the residual EDTA with an appropriate standardized metal solution under the specified buffer and indicator conditions. A classical procedure uses lead nitrate, hexamine and xylenol orange. Lead-containing reagents require controlled laboratory handling and waste collection. Alternative validated methods may use other back-titrants; their conditions cannot be exchanged casually.

The back-titration measures EDTA left over, so:

n(Al) = n(EDTA added) − n(back-titrant), when both complexes have 1:1 stoichiometry.

Reporting basis and factor

If content is reported as Al₂O₃, two moles of aluminium represent one mole of Al₂O₃, molar mass 101.96 g/mol. Thus 1 mL of 0.0500 M EDTA consumed by aluminium represents 2.549 mg Al₂O₃ or 3.900 mg Al(OH)₃ on the corresponding theoretical basis.

The factor applies to net EDTA consumption, not to the volume of back-titrant alone. Include aliquot and dilution factors, and state whether the answer is Al₂O₃ equivalent or Al(OH)₃ equivalent.

Worked calculation

An aliquot receives 40.00 mL of 0.0500 M EDTA. Residual EDTA requires 12.00 mL of a 0.0500 M 1:1 back-titrant. Net EDTA = 28.00 mL.

Al₂O₃ equivalent in aliquot = 28.00 × 2.549 = 71.37 mg. If the aliquot is one-fifth of the prepared sample solution, total Al₂O₃ equivalent is 356.9 mg.

Quality and storage

Check acid-neutralizing capacity, assay, pH, contaminating ions and microbial quality as appropriate. Content alone does not prove satisfactory neutralization rate. Store tightly closed under specified conditions; protect the suspension from freezing and conditions that irreversibly change its dispersion. Shake or redisperse a formulated suspension as its label requires.

6. Agents promoting bowel movements

Saline or osmotic laxatives supply poorly absorbed particles that retain water within the intestinal lumen. Increased luminal water softens contents and increases distension, which can stimulate motility. The important mechanism is water retention, not direct digestion of faecal material.

6.1 Magnesium hydroxide

Formula: Mg(OH)₂; molar mass: 58.32 g/mol. It is a white powder practically insoluble in water; a pharmaceutical aqueous suspension is commonly called milk of magnesia.

Poorly absorbed luminal solute promotes intestinal water retention; the mucosal barrier is shown in section.

Diagram labels: Intestinal mucosa: osmotic water retention; Poorly absorbed luminal solute; Epithelium; Lamina propria; Underlying tissue fluid; Net movement or retention of water in lumen.

Preparation commonly uses precipitation from a soluble magnesium salt with alkali, followed by washing to remove soluble ions:

MgCl₂ + 2NaOH → Mg(OH)₂↓ + 2NaCl

It reacts with gastric acid:

Mg(OH)₂ + 2HCl → MgCl₂ + 2H₂O

Magnesium hydroxide has both antacid and saline laxative applications. The role depends on the formulation and exposure. Magnesium remaining in the bowel contributes to osmotic water retention; absorbed magnesium is eliminated mainly through the kidneys.

For assay, an acid-base back-titration can measure acid consumed under defined conditions, or a validated complexometric method can determine magnesium. One mmol of Mg(OH)₂ theoretically neutralizes 2 mEq H⁺. Control identity, purity, dispersion and content.

Adverse effects include diarrhoea and, in susceptible patients, magnesium accumulation. Store the powder well closed; maintain the suspension under conditions specified for its formulation.

6.2 Sodium orthophosphate

Orthophosphate denotes salts of orthophosphoric acid. The name alone does not specify whether the material is NaH₂PO₄, Na₂HPO₄ or Na₃PO₄, or which hydrate is present.

Pharmaceutical saline laxative preparations commonly use monobasic sodium phosphate and dibasic sodium phosphate. Do not substitute strongly alkaline industrial trisodium phosphate merely because it also contains orthophosphate.

Specified form Chemical distinction
NaH₂PO₄ Monobasic sodium phosphate; acidic solution
Na₂HPO₄ Dibasic sodium phosphate; more alkaline than monobasic
Hydrated salt Formula mass includes the stated water of crystallization

NaH₂PO₄ + NaOH → Na₂HPO₄ + H₂O

Controlled neutralization and crystallization prepare the required form. These salts dissolve in water and increase luminal osmotic load in suitable laxative formulations. Sodium and phosphate can be absorbed; electrolyte disturbance, dehydration and renal effects are important limitations of inappropriate use.

Identity and content testing must match the actual phosphate species and hydrate. Store well closed, with moisture control appropriate to the product. A sodium phosphate buffer formula and a bowel-cleansing preparation are not interchangeable.

6.3 Sodium Potassium tartrate

Sodium Potassium tartrate, or Rochelle salt, is commonly the tetrahydrate KNaC₄H₄O₆·4H₂O, molar mass about 282.22 g/mol. It forms colourless crystals or a white crystalline powder and is soluble in water.

A preparation route neutralizes potassium hydrogen tartrate with sodium carbonate:

2KHC₄H₄O₆ + Na₂CO₃ → 2KNaC₄H₄O₆ + CO₂ + H₂O

Crystallization under suitable conditions yields the hydrated product. The equation shows the salt-forming step; water incorporated during crystallization gives the tetrahydrate.

Historically it has been used as a saline laxative and in effervescent laxative preparations. Retention of dissolved ions in the bowel contributes to water retention. Tartrate also complexes some metal ions and is used in analytical reagents; the analytical use should not be confused with its medicinal mechanism.

Confirm sodium, potassium and tartrate identity and control content, moisture and impurities. Store in a well-closed container. Calculations must use the tetrahydrate mass when that is the supplied material.

6.4 Magnesium trisilicate

Magnesium trisilicate is a hydrated magnesium silicate of variable composition, commonly represented as 2MgO·3SiO₂·xH₂O. Do not assign a fixed molar mass unless the actual hydration and analytical basis are defined.

It is a white, fine, practically water-insoluble material. It may be prepared by reacting suitable magnesium salt and silicate solutions, followed by controlled washing and drying. Material properties depend on the manufacturing conditions.

Its main pharmaceutical role is as a slow-acting antacid. Reaction with gastric acid releases magnesium ions and produces hydrated silica with protective/adsorptive properties. A simplified anhydrous bookkeeping equation is:

Mg₂Si₃O₈ + 4HCl → 2MgCl₂ + 3SiO₂ + 2H₂O

Actual pharmaceutical material and products are hydrated. Magnesium-associated laxation can occur, but magnesium trisilicate is not primarily classified as a strong saline purgative, even though it appears in the syllabus beside bowel agents.

Assay commonly determines magnesium and silica content, with loss on ignition or water-related tests as appropriate. ANC and reaction rate provide additional functional information. Store well closed and protect from contamination.

7. Gastrointestinal agents: comparisons

Agent Key action and distinguishing limitation
Sodium acid phosphate Acidic salt and buffer; phosphate and sodium load
Dilute HCl Direct acidification; corrosive if mishandled
Sodium bicarbonate Rapid antacid; CO₂ and systemic alkali/sodium load
Aluminium hydroxide gel Local antacid; constipation and phosphate binding
Magnesium hydroxide Antacid and saline laxative; magnesium accumulation risk
Sodium phosphate salts Osmotic laxation; electrolyte and renal concerns
Rochelle salt Historical saline laxative; soluble mixed-cation tartrate
Magnesium trisilicate Slow antacid; variable hydrated composition

ANC calculation

Theoretical capacity of 1.000 g pure NaHCO₃:

1.000 / 84.01 = 0.01190 mol = 11.90 mEq H⁺.

Theoretical capacity of 1.000 g pure Mg(OH)₂:

(1.000 / 58.32) × 2 × 1000 = 34.29 mEq H⁺.

The theoretical comparison ignores differences in dissolution, reaction rate, formulation and adverse effects. Measured ANC under specified conditions is required for product comparison.

Common exam errors

  • Writing Na₂HPO₄ for sodium acid phosphate without explaining the different species.

  • Treating a wet aluminium gel as 100% Al(OH)₃.

  • Assigning a fixed hydrate to magnesium trisilicate.

  • Assuming the fastest antacid is always the preferred one.

  • Describing every salt in the bowel-agent list as a primary laxative.

  • Ignoring dilution factors or using carbonate stoichiometry for bicarbonate.

8. Antimicrobials: Mechanisms and Classification

Antimicrobial agents inhibit growth or destroy susceptible microorganisms. An antiseptic is intended for suitable living tissues; a disinfectant is intended for inanimate surfaces or materials. A sterilant must achieve destruction of all viable microorganisms, including resistant spores, under validated conditions.

These terms describe a use and performance level, not merely the name of a chemical. A concentrated disinfectant is not automatically safe as an antiseptic. Killing some organisms does not establish sterilization.

8.1 Mechanisms

  • Oxidation: peroxide and permanganate oxidize susceptible proteins, lipids and other cellular components.

  • Halogen action: iodine and hypochlorous acid attack multiple microbial targets through oxidation and chemical modification.

  • Protein or enzyme impairment: reactive chemicals alter essential functional groups and disrupt metabolism.

  • Local physicochemical action: acidity and other conditions influence microbial growth, although weak-acid activity is usually limited.

Reactive antimicrobial species can damage the bacterial envelope, proteins and nucleic acids.

Diagram labels: Reactive agents damage microbial targets; Cell envelope; Proteins/enzymes; Nucleic acid; Oxidation and chemical modification impair multiple targets; Activity needs adequate contact.

8.2 Classification

Chemical class Syllabus examples and principal action
Oxidizing agents Hydrogen peroxide and potassium permanganate
Chlorine-releasing agents Chlorinated lime; active chlorine species
Iodine and iodophors Iodine preparations; povidone-iodine
Weak acidic antiseptic Boric acid; limited historical/local activity

8.3 Factors affecting activity

Concentration, contact time, temperature, pH and organic load affect antimicrobial performance. Blood, pus and other organic matter may consume an oxidant before it reaches microorganisms. Resistant forms and biofilms require particular consideration.

The formulation influences access to targets, solubility and chemical stability. For chlorine systems, the HOCl/OCl⁻ balance depends strongly on pH; for iodine, iodide and carrier complexes alter free iodine availability.

Mechanistic precision

Do not explain every oxidizing agent simply as releasing “nascent oxygen.” State the reactive species or oxidation reaction and the susceptible microbial targets.

9. Potassium permanganate

Formula: KMnO₄. Molar mass: 158.03 g/mol. It consists of dark purple crystals giving an intensely purple aqueous solution. It is a strong oxidizing agent whose reduction product depends on the medium.

Preparation and chemistry

Industrial routes oxidize manganese compounds to manganate under alkaline conditions, followed by conversion to permanganate, often electrochemically. Purification and crystallization yield the required product; this is not a casual laboratory preparation for clinical use.

In acidic medium:

MnO₄⁻ + 8H⁺ + 5e⁻ → Mn²⁺ + 4H₂O

In neutral or weakly alkaline conditions, reduction commonly gives brown manganese dioxide:

MnO₄⁻ + 2H₂O + 3e⁻ → MnO₂↓ + 4OH⁻

Antimicrobial action and applications

Permanganate oxidizes susceptible microbial and tissue constituents. Very dilute, properly prepared solutions have selected antiseptic and dermatological applications. It can also act as an oxidizing disinfectant in appropriate processes.

Concentrated solutions and undissolved crystals can cause severe chemical burns. Organic material consumes oxidizing capacity; the presence of purple colour alone does not prove adequate disinfection.

Identification, assay and storage

The characteristic solution colour and potassium reactions support identity. Redox assay can use a suitable standardized reducing agent, or an iodometric procedure in which permanganate liberates iodine from excess iodide in acid and the iodine is titrated with thiosulphate.

2MnO₄⁻ + 10I⁻ + 16H⁺ → 2Mn²⁺ + 5I₂ + 8H₂O

I₂ + 2S₂O₃²⁻ → 2I⁻ + S₄O₆²⁻

One mole of KMnO₄ corresponds to five moles of thiosulphate in this acidic iodometric scheme. Conditions and blank correction must match the method.

Store in a tightly closed container away from reducing agents, readily oxidizable organic substances and incompatible materials. Avoid contaminating the reagent with unsuitable stoppers or utensils.

10. Boric acid

Formula: H₃BO₃, also written B(OH)₃. Molar mass: 61.83 g/mol. It is a white crystalline material, moderately soluble in water and more soluble in hot water.

Preparation and acidic behaviour

Acidification of a suitable borate solution releases boric acid; cooling the concentrated solution crystallizes the product. A simplified preparation from borax is:

Na₂B₄O₇·10H₂O + 2HCl → 4H₃BO₃ + 2NaCl + 5H₂O

Boric acid behaves principally as a Lewis acid in water, accepting hydroxide rather than losing three protons successively as a conventional triprotic acid:

B(OH)₃ + H₂O ⇌ B(OH)₄⁻ + H⁺

Its aqueous acidity is weak. Ordinary direct titration with strong base gives an indistinct endpoint unless the analytical conditions are modified.

Assay and identity

Addition of a polyol such as mannitol or glycerol forms a boron complex with increased apparent acidity. A defined alkalimetric procedure can then titrate with standardized sodium hydroxide, using an appropriate endpoint and a polyol blank when required.

Under a validated 1:1 equivalence scheme, 1 mL of 0.100 M NaOH corresponds to 6.183 mg H₃BO₃. The factor is not evidence that boric acid is a strong monoprotic proton donor in plain water.

Identity uses appropriate borate reactions. Characteristic tests may involve formation of a volatile borate ester, but such laboratory tests require controlled handling of flammable reagents and are not medicinal preparation steps.

Uses and limitations

Boric acid has historical and selected local antiseptic applications and is a formulation/buffer ingredient. Antimicrobial activity is comparatively mild and cannot be assumed sufficient for disinfection or sterilization.

Toxicity limits inappropriate exposure, especially ingestion and extensive use on damaged tissue. Ophthalmic preparations, where applicable, require a validated sterile formulation; a homemade boric acid solution is not equivalent.

Store well closed and control purity and water-related changes according to the material specification.

11. Hydrogen peroxide

Formula: H₂O₂. Molar mass: 34.014 g/mol. Pharmaceutical preparations are aqueous solutions of specified strength. They are clear and colourless; concentration affects oxidizing power, stability and hazard.

Structure and preparation

The molecule contains an O–O single bond; it is not an oxygen gas molecule dissolved in water. The isolated molecule is non-planar, and its geometry depends on the environment.

Hydrogen peroxide contains a peroxide single bond and a non-planar molecular arrangement.

Diagram labels: Hydrogen peroxide: non-planar H–O–O–H; Two O atoms; Two H atoms; O–O single bond; Solid wedge: bond toward the viewer; Orientation shown schematically; The molecule is not a flat four-atom chain.

Modern industrial manufacture commonly uses an anthraquinone-based oxidation/reduction cycle. A classical chemical preparation uses barium peroxide with dilute sulphuric acid:

BaO₂ + H₂SO₄ → BaSO₄↓ + H₂O₂ The insoluble barium sulphate is separated. The reaction explains the chemistry, but pharmaceutical material also needs validated purification, concentration control and impurity limits.

Mechanism, decomposition and uses

Peroxide oxidizes susceptible microbial components. Catalase and other catalysts accelerate oxygen evolution:

2H₂O₂ → 2H₂O + O₂↑

Effervescence can mechanically assist removal of debris, but bubbling alone does not establish antimicrobial effectiveness. Tissue compatibility and the intended formulation matter; concentrated peroxide is damaging.

Uses include selected antiseptic/disinfectant formulations, oxidation and bleaching processes. Not every peroxide concentration or formulation is suitable for living tissue.

Stability and storage

Light, heat, trace metals, alkaline conditions and contamination can accelerate decomposition. Stabilizers may be included. Store in compatible, light-protective containers under the specified conditions, with pressure management appropriate to the product. Never assume that a decomposing solution is safe to seal in an unsuitable rigid container.

Assay: acidic permanganometry

A defined diluted aliquot is acidified with sulphuric acid and titrated with standardized potassium permanganate. The endpoint is the first persistent pale pink colour from a slight excess of permanganate.

2MnO₄⁻ + 5H₂O₂ + 6H⁺ → 2Mn²⁺ + 5O₂ + 8H₂O

Here peroxide acts as a reducing agent toward permanganate, although it commonly acts as an oxidizing antimicrobial. A substance can have different redox roles with different reaction partners.

Do not transfer the heating conditions used for oxalate standardization automatically to this assay. Unnecessary heating can decompose peroxide and change the result. Sulphuric acid supplies the required acidic medium without the chloride interference associated with hydrochloric acid.

Factor and worked example

One mole of MnO₄⁻ reacts with 2.5 mol H₂O₂:

1 mL of 0.0200 M KMnO₄ ≡ 1.7007 mg H₂O₂.

A diluted aliquot representing 1.00 mL of the original solution consumes 17.60 mL of 0.0200 M KMnO₄.

H₂O₂ in original 1.00 mL = 17.60 × 1.7007 = 29.93 mg.

Strength = 2.993 g per 100 mL = 2.993% w/v.

Permanganate oxidizes peroxide in sulphuric acid; oxygen evolves and excess titrant gives a pale pink endpoint.

Diagram labels: Acidic permanganate assay of peroxide; Standard KMnO₄; Diluted H₂O₂ + H₂SO₄; O₂ evolves; Endpoint: persistent pale-pink excess MnO₄⁻.

If a blank is required, use corrected titrant volume. If the aliquot represents a different original volume, divide by that represented volume before expressing % w/v.

Volume strength

Volume strength is the volume of oxygen, at specified gas reference conditions, obtainable from one volume of peroxide solution on complete decomposition. It is not the percentage concentration.

At approximately 0°C and 1 atm, 1 mol ideal gas occupies 22.414 L. One mole H₂O₂ gives half a mole O₂. Therefore:

Volume strength ≈ 3.29 × concentration (% w/v).

A 3.0% w/v solution is approximately 9.9-volume, conventionally near 10-volume. Changing the gas reference conditions changes the exact numerical relation.

12. Chlorinated lime

Chlorinated lime, or bleaching powder, is produced by chlorinating hydrated lime. It is a variable mixture containing hypochlorite, chloride, hydroxide and water-related components. CaOCl₂ is a conventional simplified representation; it should not be treated as a uniquely pure molecule describing every commercial material.

Preparation and properties

Chlorine is brought into controlled contact with calcium hydroxide. A simplified reaction is:

2Ca(OH)₂ + 2Cl₂ → Ca(OCl)₂ + CaCl₂ + 2H₂O

The solid is a pale powder with a characteristic chlorine-related odour. It is only partly soluble, and dispersions may leave insoluble material. Moisture, heat, carbon dioxide and contaminants affect stability and active chlorine content.

Antimicrobial mechanism

Hypochlorite establishes an aqueous equilibrium:

HOCl ⇌ H⁺ + OCl⁻

Hypochlorous acid (HOCl) has strong antimicrobial activity through oxidation and modification of essential microbial components. The fraction present as HOCl decreases as pH becomes more alkaline. Organic matter consumes active chlorine, reducing the amount available for disinfection.

Uses include environmental and water disinfection in controlled processes and bleaching. It is not a routine skin antiseptic. Do not mix hypochlorite products with acids or ammonia: hazardous gases can be generated.

Available chlorine

Available chlorine expresses oxidizing capacity as an equivalent mass of Cl₂. It is different from the total mass of all chlorine atoms in the powder; chloride contributes to total chlorine but is not an equivalent disinfecting oxidant.

Actual available chlorine depends on grade, age and storage. Determine it by assay instead of assuming every powder contains a fixed percentage.

Iodometric assay

Prepare a representative sample dispersion/extract according to the method. Add excess potassium iodide and acid under controlled conditions; active chlorine liberates iodine. Titrate promptly with standardized sodium thiosulphate, adding starch near the endpoint.

OCl⁻ + 2I⁻ + 2H⁺ → I₂ + Cl⁻ + H₂O

I₂ + 2S₂O₃²⁻ → 2I⁻ + S₄O₆²⁻

The disappearance of the blue starch-iodine colour indicates the endpoint. Avoid iodine loss, excessive delay and interfering oxidants or reducing agents. Acidification here is a controlled analytical step in an appropriate laboratory, not a recommendation to mix household chemicals.

Iodine released by available chlorine is reduced to iodide during thiosulphate titration.

Diagram labels: Available chlorine: iodometric endpoint; Before titration; After endpoint; S₂O₃²⁻; Iodine liberated; Iodide formed; Sample + excess KI + controlled acid; Starch near endpoint: blue → colourless.

Factor and calculation

One mole of Cl₂ equivalent requires 2 mol thiosulphate:

1 mL of 0.1000 M Na₂S₂O₃ ≡ 3.545 mg available chlorine.

A 1.000 g sample is prepared to 250.0 mL. A 25.00 mL aliquot uses 9.60 mL of 0.1000 M thiosulphate; assume a negligible blank.

Cl₂ equivalent in aliquot = 9.60 × 3.545 = 34.03 mg.

Total = 34.03 × 10 = 340.3 mg.

Available chlorine = 34.03% w/w.

The sample’s actual powder mass, aliquot fraction and standardized titrant strength must all be included.

Storage and quality

Keep in a suitable tightly closed, moisture-protective container in a cool place, away from acids, ammonia, reducing agents and organic combustible materials. Check available chlorine, identity and relevant impurities. A powder may remain visually similar while its available chlorine decreases.

13. Iodine and its preparations

Formula: I₂. Molar mass: 253.81 g/mol. Iodine is a dark, lustrous crystalline solid giving violet vapour; it has limited solubility in water and greater solubility in suitable alcohol-based media. Iodide increases its aqueous solubility by forming polyiodide species.

I₂ + I⁻ ⇌ I₃⁻

Iodide promotes iodine dissolution through formation of triiodide and related polyiodide species.

Diagram labels: Iodide supports aqueous iodine dissolution; I₂ + water; I₂ + iodide; Add KI; Limited dissolution; Polyiodide solution; I₂ + I⁻ ⇌ I₃⁻.

Preparation and mechanism

Iodine can be obtained by controlled oxidation of iodide-containing materials or processing suitable iodate-containing sources, followed by purification. Oxidation of iodide by an appropriate reagent converts I⁻ to I₂.

Iodine reacts with susceptible proteins, enzymes, membranes and other microbial targets. Free available iodine is important for activity; total iodine content alone does not define performance. Organic matter, pH, contact time and the carrier system affect activity.

Preparation Composition and distinguishing feature
Aqueous iodine–iodide solution I₂ with KI or another suitable iodide to support dissolution
Lugol-type solution Specified aqueous iodine/KI formulation; concentrations vary by specification
Tincture of iodine Alcohol-containing preparation with formulation-specific composition
Povidone-iodine Iodophor complex supplying available iodine through equilibrium release

An iodophor is a carrier complex of iodine. A labelled percentage of povidone-iodine complex is not the same number as its available iodine percentage. Compare products using the stated formulation and available-iodine basis.

Assay

Iodine can be measured by direct titration with standardized sodium thiosulphate:

I₂ + 2S₂O₃²⁻ → 2I⁻ + S₄O₆²⁻

Add starch close to the endpoint when the iodine concentration is low; disappearance of the blue colour marks completion. Avoid iodine volatilization and unnecessary delay. Matrix-specific extraction or sample preparation may be required for an iodophor or alcoholic preparation.

1 mL of 0.1000 M thiosulphate ≡ 12.690 mg I₂.

This factor differs from the available-chlorine factor even though both assays use a two-thiosulphate-per-diatomic-halogen relationship, because the molar masses differ.

Uses, quality and storage

Appropriate iodine preparations are used for skin antisepsis and selected disinfection applications. Tissue tolerance and the intended site must follow the formulation. Excess exposure can influence thyroid function; topical iodine is not the same product as radioactive sodium iodide.

Store in well-closed, light-protective, compatible containers to limit loss and deterioration. Confirm identity, available content, solvent composition where relevant and appropriate microbial/formulation quality.

Antimicrobial Selection: Examination Comparison

Agent Mechanism and characteristic limitation
KMnO₄ Strong oxidation; concentrated material burns tissue
Boric acid Weak acidic/local action; mild activity and toxicity limits
H₂O₂ Oxidation; decomposition and tissue compatibility matter
Chlorinated lime HOCl-mediated action; organic load and pH affect activity
Iodine preparations Reactive iodine species; formulation and free iodine matter

14. Basics of radioactivity

Radioactivity is spontaneous nuclear transformation of unstable nuclei with emission of particles or electromagnetic radiation. It is a nuclear event; dissolving a radionuclide or changing its chemical bonding does not ordinarily stop its radioactive decay.

A nuclide is defined by its numbers of protons and neutrons. Isotopes of one element have the same atomic number but different mass numbers. A radionuclide is an unstable nuclide; a radiopharmaceutical is a medicinal preparation containing a radionuclide for diagnosis or therapy.

14.1 Nuclear notation and emissions

In nuclear notation, A is the mass number written at the upper left of the element symbol and Z is the atomic number written at the lower left. For example, iodine-131 has 53 protons and 78 neutrons. The number after a name is not its activity or its pharmaceutical concentration.

Radiation Nature and characteristic behaviour
Alpha (α) Helium nucleus; +2 charge, high ionization, short range
Beta minus (β⁻) Electron from nuclear transformation; continuous energy spectrum
Beta plus (β⁺) Positron; annihilation gives paired 511 keV photons
Gamma (γ) Photon; no charge, relatively penetrating

Alpha decay reduces A by 4 and Z by 2. In beta-minus decay, a neutron becomes a proton, so Z increases by 1 while A remains unchanged; an electron and an antineutrino are emitted. Gamma emission lowers nuclear excitation without changing A or Z.

A metastable nucleus has an excited state with a measurable lifetime. Technetium-99m contains the suffix m for metastable; it is not an element different from technetium.

14.2 Activity and decay law

Activity is the rate of nuclear disintegrations:

A = λN, where λ is the decay constant and N the number of undecayed radioactive nuclei.

N(t) = N₀ × exp(−λt); A(t) = A₀ × exp(−λt).

Physical half-life: T½ = ln 2 / λ ≈ 0.693 / λ.

Equivalent working equation: A(t) = A₀ × 2^(−t/T½).

The time and half-life must use the same units. After each half-life, the remaining activity halves; decay is exponential rather than subtraction of a constant amount per hour.

Normalized activity decreases exponentially with elapsed physical half-lives.

Diagram labels: Physical decay: normalized activity; A/A₀ axis from 0 to 1; Elapsed physical half-lives from 0 to 4; After 1, 2 and 3 half-lives: 1/2, 1/4 and 1/8.

14.3 Units that must not be confused

Quantity Unit and meaning
Activity Becquerel (Bq): one disintegration per second
Older activity unit One curie (Ci) = 3.7 × 10¹⁰ Bq
Absorbed dose Gray (Gy): one joule deposited per kilogram
Equivalent/effective dose Sievert (Sv): radiation- or tissue-weighted quantities
Photon or particle energy Electronvolt (eV), often keV or MeV

MBq means one million Bq; GBq means one billion Bq. Activity describes a source, while absorbed dose describes energy deposited in matter. One MBq cannot be converted to one fixed number of mGy without geometry, emitted energy, exposure time and absorption information.

15. Half-Lives and Radiopharmaceutical Selection

15.1 Physical, biological and effective half-life

Physical half-life describes radioactive decay. Biological half-life describes removal from a biological compartment by physiological processes. Effective half-life combines these losses when both follow suitable independent first-order kinetics:

1/Teff = 1/Tphys + 1/Tbio.

Equivalently, Teff = (Tphys × Tbio)/(Tphys + Tbio). It is shorter than either individual half-life when both are finite. Real multicompartment biological behaviour may require more than one exponential.

Worked effective half-life

If Tphys = 8.0 days and Tbio = 12.0 days:

Teff = (8.0 × 12.0)/(8.0 + 12.0) = 4.8 days.

This is a mathematical illustration, not a universal clearance value for iodine-131 in every patient or organ.

15.2 Diagnostic and therapeutic selection

Diagnostic tracers should reach a useful target distribution and provide detectable radiation while keeping exposure appropriate. Gamma photons can be detected outside the body for conventional nuclear imaging. A suitable physical half-life allows preparation and examination without unnecessary prolonged activity.

Therapeutic radionuclides deposit radiation energy in a selected tissue or target. Their particle emission, energy, range, targeting and residence time influence effectiveness and unwanted exposure. Chemical carrier and radionuclide properties must be considered together.

Selection factor Why it matters
Emission type and energy Detection efficiency or local energy deposition
Physical half-life Preparation, transport and duration of exposure
Chemical form Target distribution and biological clearance
Specific activity Activity relative to amount of material
Purity and stability Intended species and predictable biodistribution
Availability Production and reliable access to suitable material

15.3 Types of purity

Radionuclidic purity: fraction of total activity due to the intended radionuclide. Radiochemical purity: fraction of activity in the intended chemical form. Chemical purity: absence or control of nonradioactive chemical contaminants.

These tests answer different questions. A preparation can contain the correct radionuclide but an undesirable radiochemical form, leading to incorrect localization.

Injectable preparations additionally require suitable sterility, bacterial endotoxin control and other product-specific attributes. Radionuclide identity does not prove injectable quality.

Pharmaceutical label essentials

State radionuclide, chemical form, activity at a defined calibration date/time, volume or activity concentration where relevant, batch identification, expiry and required handling information. Activity without its reference time can be misleading.

16. Sodium Iodide I-131

Sodium iodide containing iodine-131 supplies radioactive iodide, commonly in a pharmaceutical solution or capsule. Iodine-131 has a physical half-life of approximately 8.02 days, emits beta-minus particles and associated gamma photons, including an important photon near 364 keV.

Biological targeting

Thyroid cells actively take up iodide from blood using the sodium-iodide symporter. Iodide can be incorporated into thyroid hormone-related material. This selective uptake connects the chemical form to both diagnostic information and therapeutic irradiation.

The thyroid lobes and isthmus surround the anterior tracheal region and selectively take up iodide.

Diagram labels: Thyroid gland: anterior anatomical view; Thyroid cartilage; Pyramidal lobe; Thyroid lobes; Isthmus; Trachea; Patient right is on the left of this view; A pyramidal lobe is an anatomical variant.

Applications

  • Selected thyroid uptake and functional investigations.

  • Therapy for hyperthyroidism in appropriate clinical settings.

  • Treatment of suitable differentiated thyroid cancer and functioning iodine-avid disease. Beta radiation contributes to treatment within iodine-accumulating tissue. Gamma emission enables detection but also contributes to external exposure considerations. Iodine-131 is not universally preferred for every thyroid imaging situation.

Pharmaceutical control and handling

Confirm radionuclide identity, iodide radiochemical purity, activity, formulation quality and expiry. Some chemical iodine forms may have a different biodistribution from iodide. The labelled activity changes with decay and must be interpreted at the calibration time.

Use shielding and contamination controls appropriate to beta/gamma emissions. Iodine-containing volatile contamination may require additional controls according to the preparation and process. Clinical pregnancy/breastfeeding assessment and patient instructions belong to specialist protocols.

Stable iodide used for specified thyroid-blocking applications is chemically related but not equivalent to radioactive NaI. Mixing these concepts can reverse the intended effect on uptake.

Decay example

A sodium iodide preparation has 400 MBq at the reference time. After 16.04 days, two physical half-lives have elapsed:

A = 400 × (1/2)² = 100 MBq.

This calculates source decay only; activity retained in a patient can also change through biological elimination.

17. Technetium-99m

Technetium-99m (⁹⁹ᵐTc) is a metastable radionuclide with a physical half-life of approximately 6.0 hours. Its important gamma emission is near 140 keV, suitable for many gamma-camera examinations.

It decays principally by isomeric transition to technetium-99. Tc-99 is long-lived and radioactive; the transition does not instantly turn all material into a stable, harmless element.

17.1 Molybdenum-99/Technetium-99m Generator

Molybdenum-99 has a half-life of approximately 66 hours and produces Tc-99m among its decay products. In a common generator, molybdate is retained on an alumina column while technetium can be eluted as pertechnetate, TcO₄⁻, using suitable sterile saline.

The eluate can be used in appropriate formulations or combined with validated kits to form radiolabelled compounds. Elution removes available daughter activity; fresh Tc-99m subsequently grows in from retained parent material. Exact daughter growth depends on the decay scheme and elapsed time.

17.2 Applications

Tc-99m preparations support imaging of organs and physiological processes. Different labelled compounds are used for bone, kidney, hepatobiliary, cardiac and other examinations. Pertechnetate has its own distribution and may be used for selected thyroid, salivary gland and related studies.

The radionuclide name alone does not identify the target organ. The ligand/carrier and chemical form govern the distribution of a kit-labelled preparation.

Saline elutes pertechnetate through connected tubing while molybdenum remains on the shielded alumina column.

Diagram labels: Mo-99/Tc-99m column generator: section; Saline vial; Alumina + Mo-99; Shield housing; Evacuated vial; TcO₄⁻ eluate; Mo retained; Tc eluted.

17.3 Quality control

Generator eluate requires controls for activity, radionuclidic contamination such as molybdenum breakthrough, chemical impurities such as aluminium, and product-specific pharmaceutical quality. After labelling, radiochemical purity assesses whether activity is in the intended compound rather than free pertechnetate or other unwanted species.

Short half-life makes calibration time, preparation time and expiry particularly important. A dose calibrator measures activity; a gamma camera forms distribution images. They are different instruments.

Calculation

An eluate contains 1200 MBq at 08:00. Ignoring any replenishment from parent material after collection, its Tc-99m activity at 14:00 is:

1200 × 2^(−6/6) = 600 MBq.

At 20:00, after two half-lives, it is 300 MBq. Calculating an administered quantity would additionally require the prescribed activity, residuals and time of use; this example is only decay arithmetic.

18. Cobalt-60 and Phosphorus-32

18.1 Cobalt-60

Cobalt-60 has a physical half-life of approximately 5.27 years. It undergoes beta-minus decay to excited nickel-60, which emits prominent gamma photons near 1.17 and 1.33 MeV.

It is commonly produced by neutron activation of cobalt-59. Its energetic gamma radiation is useful for sealed-source external radiotherapy and irradiation/sterilization processes in properly designed facilities.

Co-60 is included here as a medical radioisotope; it is not a routine injectable radiopharmaceutical. Its sealed-source applications differ fundamentally from unsealed iodine-131 or Tc-99m preparations.

Source encapsulation, secure storage, interlocks, remote handling, source inventory and integrity controls are central. The source remains hazardous for a long period and must be transferred or returned through an authorized route.

18.2 Phosphorus-32

Phosphorus-32 has a physical half-life of approximately 14.3 days. It is principally a beta-minus emitter with a maximum beta energy near 1.71 MeV; its beta spectrum has a range of energies rather than every particle having the maximum energy.

It can be used in phosphate-containing tracer preparations, biomedical research and selected specialist therapeutic applications, including some haematological indications. Its usefulness depends on chemical form and clinical context, not simply on the presence of phosphorus.

Phosphate incorporation relates to cellular and bone metabolism, but different preparations do not all localize identically. Therapeutic selection and administration require specialist protocols.

Shielding distinction

For energetic beta particles, a low atomic-number material, such as acrylic, is commonly used first to reduce beta exposure while limiting bremsstrahlung production. Additional shielding may be needed for secondary photons. For gamma emitters, appropriately designed lead or tungsten shielding is commonly useful.

Do not draw or describe a single sheet that makes all radiation disappear. Attenuation depends on radiation energy, material thickness and geometry; shielding complements time, distance and contamination control.

Low-Z shielding is useful for beta particles; dense shielding attenuates penetrating gamma photons.

Diagram labels: Select shielding for the emitted radiation; β⁻ source; γ source; Low-Z acrylic; Limits beta exposure and bremsstrahlung generation; Lead/tungsten; Attenuated photon field; Shielding reduces exposure and is not absolute.

Isotope Approximate physical half-life Emission and major role
I-131 8.02 days β⁻ + γ; iodine-avid thyroid applications
Tc-99m 6.0 hours γ/isomeric transition; diagnostic imaging preparations
Co-60 5.27 years β⁻ + high-energy γ; sealed-source irradiation
P-32 14.3 days β⁻; tracer and selected therapeutic uses

19. Safe Handling: Radiation and Contamination

ALARA means keeping exposure as low as reasonably achievable, taking account of the justified task. Protection combines time, distance and shielding with contamination control. A well-shielded source can still contaminate a surface if unsealed material is spilled.

19.1 Time, distance and shielding

Plan work before opening or handling material. Use efficient procedures and suitable remote tools to reduce exposure time and hand proximity. Increase distance where compatible with the task; select shielding for the radionuclide and emission.

For an approximate point source in a suitable unobstructed geometry:

Intensity ∝ 1/r².

Doubling distance from 0.5 m to 1.0 m gives about one-quarter of the intensity. The approximation is limited by extended sources, attenuation, scattering and changing geometry; it is not an exact universal workplace-dose rule.

19.2 Preventing contamination

  • Work only in authorized, designated areas with suitable surfaces and containment.

  • Use the specified protective clothing, gloves and handling tools; prevent transfer between clean and radioactive areas.

  • Never eat, drink or use mouth pipetting in a radioactive work area.

  • Label materials clearly and keep a traceable inventory.

  • Monitor work areas, instruments and personnel as the procedure requires.

  • Use sealed containers and secondary containment appropriate to the radionuclide and physical form.

19.3 Monitoring and measurement

A dose calibrator commonly uses a well-type ionization chamber to measure activity in a vial or syringe with radionuclide-specific settings. Geometry, calibration and container type can influence the reading.

A survey meter measures a specified radiation field or detects contamination depending on its detector and calibration. A wipe test assesses removable surface contamination; it does not directly reveal all fixed contamination. Personal dosimeters assess relevant worker exposure over their intended measurement period.

A Geiger-Müller detector is not automatically a quantitative dose calibrator. Instrument selection must account for radiation type, energy, sensitivity, calibration and possible saturation.

A well-type ionization chamber measures sample activity using defined calibration and geometry.

Diagram labels: Well-type ionization-chamber dose calibrator; MBq; Sample vial; Detector gas; Well; Use calibrated radionuclide settings and a defined vial/syringe measurement geometry.

19.4 Spills and abnormal events

Stop the task, restrict access and notify the designated radiation safety personnel. Follow the facility’s established response procedure, including appropriate monitoring, containment and controlled decontamination. Collect cleanup material as the required waste category and document the incident.

Do not improvise cleanup without knowing the radionuclide, chemical hazard and activity. Routine detergent chemistry does not remove radioactivity by changing nuclear decay; it may move contaminated material into another collected phase.

20. Storage, disposal and regulatory safety

20.1 Storage principles

Store radioactive materials in an authorized, secure area with suitable shielding and secondary containment. Segregate incompatible chemicals and distinguish sealed sources, unsealed preparations and radioactive waste. Restrict access to authorized personnel.

Labels and records should identify radionuclide, activity with its reference time, chemical/physical form, receipt or preparation date, batch/source identity and responsible control information. Use periodic inventory and monitoring to maintain traceability.

A short physical half-life does not remove chemical, biological or sharps hazards. Radioactive peroxide, an organic tracer solution and a sealed cobalt source would require different storage considerations.

20.2 Waste segregation

Separate waste by radionuclide and half-life, physical form and additional hazard. Use compatible, labelled collection containers for solids, liquids, sharps and relevant biological materials. Avoid unnecessary mixing that makes later characterization and disposal more difficult.

Short-lived materials may qualify for decay storage where authorized. Release requires the prescribed assessment, survey, documentation and criteria; elapsed time alone is insufficient.

After ten half-lives, activity is approximately 1/1024 of the initial value. This arithmetic does not automatically authorize disposal as ordinary waste, especially when starting activity is high or long-lived contamination is present.

20.3 Long-lived and sealed-source waste

Long-lived radionuclides and disused sealed sources require authorized management or transfer. A Co-60 source must not be discarded into ordinary refuse or casually opened. Return to an authorized supplier or transfer to an approved waste-management route as the applicable arrangements require.

Liquids must not be discharged merely because they look clear. Permitted routes, activity limits, chemical restrictions and records depend on the authorization and applicable regulations.

20.4 Indian regulatory context

In India, the Atomic Energy Regulatory Board (AERB) regulates radiation safety for relevant facilities and practices within the applicable legal framework. An institution must hold the required authorization and comply with its conditions before procuring, possessing or using regulated radioactive material.

Radiation safety responsibilities include an appropriate radiation safety officer, trained personnel, approved facility/equipment arrangements, occupational monitoring, quality assurance, secure source control and incident reporting as applicable.

Control area Expected institutional responsibility
Authorization Operate within approved practice and conditions
Training Competent staff with defined responsibilities
Worker protection Monitoring, safe procedures and exposure control
Material security Traceable inventory and restricted access
Waste management Segregation and authorized disposal or transfer
Incident response Prepared procedures, assessment and required reporting

Specific dose limits, release criteria, transport requirements and reporting duties must be taken from the current applicable rules, guidance and facility authorization. A classroom note should not invent one numerical limit for every source, worker and disposal route.

Safety logic

Radioactive decay reduces activity. Safe release is a regulated decision supported by characterization and measurement, not a visual judgement or a half-life count alone.

21. Integrated calculations and error control

21.1 General assay calculation

Mass found (mg) = corrected titrant volume (mL) × factor (mg/mL) × dilution factor.

% w/w = mass found / original sample mass × 100, with both masses in the same units.

For an aqueous liquid result in % w/v, first find grams in the represented original volume, then scale to 100 mL. Do not divide by an arbitrary gram sample mass when the specification is volume-based.

Assay reagent Factor for the stated conditions
0.200 M HCl 16.802 mg NaHCO₃ per mL
0.0500 M EDTA consumed 2.549 mg Al₂O₃ equivalent per mL
0.0200 M KMnO₄ 1.7007 mg H₂O₂ per mL
0.1000 M thiosulfate 3.545 mg Cl₂ equivalent per mL
0.1000 M thiosulfate 12.690 mg I₂ per mL

All factors depend on stated molarity, balanced reaction and reporting basis. If the standardized strength differs, adjust the factor proportionately.

21.2 Non-integer half-life example

A Tc-99m preparation has 800 MBq at 09:00. Find activity at 12:00, using a 6.0 h half-life.

A = 800 × 2^(−3/6) = 800 / √2 = 565.7 MBq.

Do not subtract half of the activity simply because half a half-life has elapsed; exponential decay gives about 70.7% remaining.

21.3 Activity concentration

A uniformly mixed preparation contains 600 MBq in 5.00 mL at the specified time. Activity concentration is 120 MBq/mL. If its activity halves and volume is unchanged, concentration becomes 60 MBq/mL.

Source activity, activity concentration and chemical molarity are different quantities. Specific activity also requires the relevant mass or molar basis to be stated.

21.4 Quality checkpoints

  • Confirm salt/hydrate identity before selecting formula mass.

  • Balance redox reactions in the actual assay medium.

  • Use net EDTA consumption for a back-titration.

  • Include aliquot, blank and reagent-strength corrections.

  • State whether halogen content means available chlorine or iodine.

  • Attach a calibration time to every radioactive activity.

  • Distinguish physical decay from biological elimination.

  • Match monitoring and shielding to the emitted radiation.

Recall cue Essential answer
NaH₂PO₄ Sodium acid phosphate; acidic phosphate salt
Dilute HCl Aqueous strong acid; neutralization assay
NaHCO₃ Rapid antacid; CO₂ evolution; 1:1 HCl
Aluminium gel Hydrated colloid; slow antacid; EDTA back-assay
Mg(OH)₂ Antacid and osmotic laxative
Sodium phosphate Specify monobasic/dibasic and hydrate
Rochelle salt KNaC₄H₄O₆·4H₂O
Magnesium trisilicate Variable hydrated silicate; mainly antacid
KMnO₄ / H₂O₂ Oxidizing antimicrobials; different assay roles
Chlorinated lime HOCl action; available-chlorine iodometry
Iodine + KI Polyiodide formation supports aqueous dissolution
I-131 / Tc-99m About 8 days thyroid applications / about 6 hours imaging
Co-60 / P-32 Sealed gamma source / beta tracer or therapy
ALARA Time, distance, shielding and contamination control

Equations to Remember

A = λN; T½ = 0.693/λ.

A(t) = A₀ × 2^(−t/T½).

1/Teff = 1/Tphys + 1/Tbio.

Volume strength ≈ 3.29 × % w/v H₂O₂ at the stated STP.

ANC depends on acid equivalents consumed under defined conditions.

Examination Practice

Long-Answer Questions

  1. Explain ideal antacid properties, combination rationale and the preparation, assay and uses of NaHCO₃ and aluminium hydroxide gel.

  2. Compare the specified bowel agents, including the distinction between magnesium trisilicate and primary saline laxatives.

  3. Describe antimicrobial mechanisms and the preparation, assay and stability of hydrogen peroxide and chlorinated lime.

  4. Explain radioactivity, half-life and the applications of I-131, Tc-99m, Co-60 and P-32.

  5. Describe authorized handling, storage, monitoring and radioactive waste management.

Short-Answer Questions

  • Why is a wet gel not equivalent to pure Al(OH)₃ by mass?

  • Why add mannitol in a boric acid assay?

  • Why is starch added near the iodometric endpoint?

  • Why does a 10% iodophor label not mean 10% free iodine?

  • Distinguish radionuclidic and radiochemical purity.

  • Why use low-Z shielding first for energetic beta particles?

Self-Check Numericals

  1. 20.00 mL of 0.2000 M HCl reacts with NaHCO₃. Mass found? 336.04 mg.

  2. 10.00 mL of 0.0200 M KMnO₄ reacts with H₂O₂. Mass found? 17.007 mg.

  3. A 2.0% w/v peroxide solution has what approximate volume strength at STP? 6.58-volume.

  4. A 160 MBq source undergoes three physical half-lives. Remaining activity? 20 MBq.

  5. Physical and biological half-lives are both 10 d. Effective half-life? 5 d.

Final Examination Check

Name the exact chemical form, explain its mechanism, give a balanced relevant reaction, state assay stoichiometry and connect each precaution to its chemical or radiation basis.

22. Detailed Explanations for Complete Understanding

22.1 Relating a Gastrointestinal Agent to Its Site of Action

A chemical formula identifies a substance, but it does not independently establish its pharmaceutical role. The same salt can behave differently when supplied in another formulation, amount or site of application. Inorganic gastrointestinal agents must therefore be studied through both their reactions and their location of action. Acidifiers increase acidity in a specified system, antacids consume existing acid, and suitable osmotic bowel agents retain water in the intestinal lumen.

The stomach provides an acidic environment in which a poorly soluble hydroxide can still react. Low water solubility does not mean absence of antacid action. Acid consumes hydroxide at the particle surface, allowing further reaction under the formulation’s conditions. Conversely, a readily soluble salt may introduce an absorbed electrolyte or alkali load in addition to its local effect.

The intestinal action of a poorly absorbed solute involves water retention. It is not the same chemical process as neutralizing hydrochloric acid. A salt listed beside laxatives should not automatically be described as a powerful primary laxative; magnesium trisilicate illustrates the need to identify the principal role accurately.

An examination answer should connect chemical identity, physical form, reaction, site, useful effect and limitation. This sequence prevents a list of uses from becoming detached from chemistry. It also explains why a formulation’s suitability cannot be judged from a formula or theoretical neutralizing capacity alone.

22.2 Keeping Acid Strength, Solution Strength and Salt Identity Separate

Dilute hydrochloric acid remains a strong acid because the dissolved acid ionizes extensively under ordinary dilute aqueous conditions. The word dilute describes concentration, whereas strong describes acid behaviour. A small concentration of a strong acid and a larger concentration of a weak acid cannot be compared using those adjectives alone.

Sodium acid phosphate supplies acidity through phosphate equilibrium. Sodium dihydrogen phosphate, sodium hydrogen phosphate and trisodium phosphate have different degrees of neutralization. Their common sodium and phosphate constituents do not make them interchangeable. The monobasic salt can give an acidic solution, whereas the more highly neutralized salts behave differently.

Hydration adds another independent identity question. A mass calculation using anhydrous sodium dihydrogen phosphate does not apply automatically to a hydrate. Water of crystallization changes the formula mass and therefore the amount of phosphate represented by a gram. It does not create additional phosphate units in each formula unit.

When an acidifier question is numerical, first identify the actual species and material form. Then state which acid-base change the endpoint measures. In a solution assay, distinguish the concentration of HCl from the total mass or volume of its aqueous preparation. Clear reporting of those quantities prevents a correct reaction from being attached to an incorrect sample basis.

22.3 Understanding Acid-Neutralizing Capacity as a Defined Test

Theoretical capacity follows a balanced equation. One millimole sodium bicarbonate consumes one millimole hydrogen ions, equal to one milliequivalent of acid. One millimole magnesium hydroxide can consume two milliequivalents, while one millimole pure aluminium hydroxide can consume three. These relationships describe the ideal chemical amounts.

An experimental acid-neutralizing-capacity result also reflects how much reaction occurs during a specified test. Particle size, dispersion, contact time, agitation, dissolution and endpoint conditions influence the observed performance. A slowly reacting material may not deliver its complete theoretical capacity within the same test interval as another formulation.

Consequently, comparing products only by milligrams is misleading. Comparing only ideal acid equivalents can also miss an important rate difference. A wet gel introduces the further issue that much of its mass is water. The weighed mass cannot be treated as pure Al(OH)₃ without the specified content basis.

For examination purposes, distinguish three questions: how much acid could a defined pure substance neutralize, how rapidly does the formulated material react, and what capacity is measured by the prescribed test? These questions are related but not identical. A complete answer explains why chemical content and functional performance are both relevant to antacid quality.

22.4 Explaining the Rationale and Limits of Antacid Combinations

Antacid combinations seek complementary properties rather than simply a larger list of ingredients. Aluminium-containing agents tend toward constipation, while magnesium-containing agents tend toward looser stools. Combining appropriate components can balance these tendencies and can bring together different reaction rates and capacities. The final behaviour depends on the formulation and its proportions.

Balancing tendencies does not guarantee that every user experiences no bowel effects. Individual responses, exposure and renal handling remain relevant. Similarly, combining rapid and slower neutralization does not prove that the mixture is superior under every condition. Product quality must still be established through suitable testing.

The combination may also contain an ingredient addressing gas symptoms. Such an ingredient should not be assigned an acid-neutralizing capacity unless its own chemistry supports that role. A symptom-directed component and an acid-consuming component can have different functions within the same preparation.

Drug interactions can arise from altered gastric pH or direct binding and complexation. The appropriate interpretation depends on the other medicine and the product. It is not accurate to attach one universal timing interval to all antacids and all medicines. In an academic comparison, identify the interaction mechanisms and the need for formulation-specific information rather than inventing a single rule for every case.

22.5 Separating Bicarbonate From Carbonate in an Assay

Sodium bicarbonate and sodium carbonate are related but have different complete acid-neutralization ratios. Bicarbonate consumes one mole acid per mole, while carbonate consumes two at full neutralization. Confusing these ratios creates a factor-of-two error before any dilution or percentage calculation is attempted.

For sodium bicarbonate, one millilitre of 0.2000 mol/L HCl contains 0.2000 mmol acid and represents the same bicarbonate amount. Multiplying by 84.01 mg/mmol gives 16.802 mg. This derivation is preferable to recalling the factor without its concentration and reaction basis.

Carbon dioxide evolution explains both effervescence and an analytical consideration. The gas and dissolved carbon dioxide species can influence mixing and endpoint behaviour. The procedure’s handling of the endpoint region should therefore be followed consistently. The reaction should not be treated as an instruction to heat every bicarbonate assay indiscriminately.

Excessive heating of sodium bicarbonate itself can produce carbonate, changing the composition of the material being weighed or tested. Storage and preparation conditions therefore connect directly to assay identity. A solution or powder that has changed chemically cannot be assumed to retain the same bicarbonate factor merely because the original container was labelled NaHCO₃.

22.6 Understanding a Gel as a Pharmaceutical Material

Aluminium hydroxide gel is a hydrated dispersed material rather than a container filled with pure dry aluminium hydroxide. Its water content, particle properties and dispersion influence both the mass basis and its interaction with acid. A stated quantity of wet gel must be interpreted using the specified content or assay basis.

The chemical representation Al(OH)₃ is useful for balancing acid reaction. It does not imply that every gram of gel contains one gram of anhydrous Al(OH)₃. Drying produces another material with a different water content, and changes in ageing or drying can alter reactivity. Wet and dried products are not automatically equivalent by mass.

The gel is amphoteric. It reacts with acid by consuming hydrogen ions and can dissolve in sufficiently strong alkali as aluminate. These two reactions explain why precipitation conditions require control. An excessive alkaline environment can redissolve material that the process intended to isolate.

For quality control, chemical content and acid-neutralizing behaviour answer different questions. A product can contain the expected aluminium amount yet have an unsuitable reaction rate or dispersion. A complete description should therefore include physical form, preparation controls, content assay, functional performance and storage. This reasoning also explains why simply quoting the dry hydroxide formula is insufficient for a pharmaceutical gel question.

22.7 Following the Aluminium–EDTA Back-Titration Logically

An aluminium gel assay can add a known EDTA excess after appropriate sample dissolution and treatment. Aluminium complex formation must proceed sufficiently before the remaining ligand is measured. The back-titrant then determines EDTA not consumed by aluminium, rather than measuring aluminium directly in the final burette step.

For one-to-one complexes, subtract residual EDTA amount from added EDTA amount. When concentrations differ, calculate both amounts separately. A volume subtraction is valid only when the actual strengths and reaction ratios justify it. Equal nominal labels alone are insufficient evidence.

The net ligand amount gives aluminium amount. If the result is expressed as Al₂O₃ equivalent, divide aluminium moles by two before applying the oxide molar mass. If expressed as Al(OH)₃ equivalent, use the corresponding one-aluminium formula. These reporting conversions explain why two different milligram factors can arise from the same net EDTA amount.

The selected back-titrant, buffer and indicator form one analytical system. Conditions from a lead-containing classical procedure cannot be transferred casually to a different metal back-titrant. A clear answer states the principle and the applicable conditions while recognizing that a validated alternative may have another reagent sequence. The factor must always refer to net EDTA consumption and the stated reporting species.

22.8 Explaining Osmotic Bowel Action Without Treating Every Salt Alike

Poorly absorbed particles in the intestinal lumen influence water movement and retention. Increased luminal water can soften contents and increase distension, supporting bowel evacuation. This physicochemical process differs from direct digestion of intestinal residue. It also differs from neutralization of stomach acid.

Magnesium hydroxide has both antacid and saline-laxative applications. Which role dominates depends on the preparation and exposure. Sodium phosphate preparations similarly require identification of monobasic and dibasic components and their hydration state. A phosphate buffer and a bowel-cleansing formulation are not interchangeable simply because both contain phosphate ions.

Absorption and elimination matter alongside local action. Magnesium, sodium and phosphate loads can produce important limitations when inappropriate quantities are used or elimination is impaired. An educational explanation should connect those limitations to ion handling without converting the notes into an unsupervised treatment regimen.

Rochelle salt introduces both sodium and potassium with tartrate. Its historical saline-laxative role should be distinguished from tartrate’s metal-complexing analytical role. Magnesium trisilicate, meanwhile, is principally a slow antacid with hydrated silicate characteristics. Listing these compounds together in a syllabus does not erase their different identities, mechanisms and principal pharmaceutical uses.

22.9 Why Magnesium Trisilicate Does Not Have One Automatic Formula Mass

Magnesium trisilicate is commonly represented as 2MgO·3SiO₂·xH₂O. The variable x indicates that water content is not fixed by that general representation. A numerical molar mass cannot be assigned universally without defining the actual composition and analytical basis. This differs from a specified crystalline hydrate with a definite number of water molecules.

A simplified anhydrous equation can show how the magnesium silicate framework reacts with acid. Such bookkeeping supports chemical understanding, but it is not a complete description of every hydrated pharmaceutical particle or final hydrated product. Both magnesium content and silica-related tests can therefore be relevant to material characterization.

Its antacid action is relatively slow, and hydrated silica contributes protective or adsorptive characteristics. Magnesium-associated laxation may occur, but the principal classification should not be replaced by an assumption that every magnesium salt is a strong saline purgative. The formulation and specific material properties remain important.

An examination answer should state the variable hydrated nature explicitly. If a question supplies an analytical percentage, loss on ignition or defined composition, use that information as directed. Do not silently substitute a fixed hydrate formula copied from another magnesium compound. The broader lesson is to establish what the weighed material represents before turning its mass into moles or theoretical capacity.

22.10 Distinguishing Antisepsis, Disinfection and Sterilization

Antisepsis concerns an appropriate antimicrobial application to living tissue. Disinfection concerns a specified reduction or destruction of organisms on inanimate materials. Sterilization requires destruction of all viable microorganisms, including resistant spores, through validated conditions. These terms describe intended application and performance rather than an unchanging property of a chemical name.

The same active substance can appear in products with different concentrations, solvents, stabilizers and contact requirements. A formulation appropriate for an inanimate surface cannot automatically be used on tissue. Conversely, mild tissue-compatible action does not establish that a preparation is a sterilant.

Contact time, temperature, pH, organism susceptibility and organic load influence performance. A visible colour or bubbling reaction can show that chemistry is occurring without proving that the complete microbial objective has been achieved. Validation connects a defined process with the required performance.

When comparing agents, explain their reactive species and targets. Oxidation, halogenation and enzyme impairment are more informative than describing all agents as releasing nascent oxygen. The selected product must make the active species available at the target while remaining compatible with its intended material or tissue. The chemical mechanism supports selection, but it does not replace evidence for the specified application.

22.11 Understanding the Effect of Organic Load

An oxidizing antimicrobial can react with many susceptible organic substances, not only microorganisms. Blood, pus and other organic material may consume active oxidant before it reaches the intended microbial targets. A preparation with adequate nominal concentration can therefore perform differently in a contaminated environment than under a cleaner test condition.

This effect helps explain why remaining colour is not an independent proof of successful disinfection. Purple permanganate or iodine colour describes the presence of coloured species, while antimicrobial performance depends on access, exposure and the complete chemical environment. A coloured solution may still have encountered shielding by organic material or insufficient contact with the target.

The formulation also affects availability. Iodide improves iodine dissolution, an iodophor controls iodine release, and pH changes the balance between hypochlorous acid and hypochlorite. Total chemical amount, free reactive fraction and microbial exposure are distinct quantities. Each can limit the final response.

For examination answers, describe organic load as a competing chemical demand and sometimes a physical barrier. Avoid assuming a fixed corrective concentration or contact time for every agent and situation. Those operating conditions belong to validated product procedures. The transferable principle is that measured content alone does not guarantee effective target exposure.

22.12 Explaining Boric Acid’s Unusual Aqueous Acidity

Boric acid is written H₃BO₃ or B(OH)₃, but its three hydrogens do not mean that it behaves as a conventional strong triprotic acid. In water, it acts principally as a Lewis acid by accepting hydroxide through the equilibrium involving tetrahydroxyborate. Its weak aqueous response makes an ordinary endpoint with strong base indistinct.

A suitable polyol, such as mannitol or glycerol in a defined assay, changes the boron complexation environment and increases apparent acidity. This permits a useful alkalimetric determination under the chosen conditions. The polyol is therefore part of the analytical chemistry rather than merely a convenient solvent additive.

An appropriate blank may be necessary because the added reagent can contribute background consumption. The one-to-one assay factor applies to the validated equivalence scheme; it does not prove that plain aqueous boric acid behaves as a strong monoprotic proton donor. Analytical stoichiometry and a simplified structural impression must not be confused.

The same precision is needed when describing uses. Historical or selected local antiseptic activity does not justify calling boric acid a powerful sterilant. A sterile ophthalmic formulation also requires more than dissolving the chemical in water. State identity, analytical modification, endpoint, factor and limitations together so the answer connects chemical behaviour with pharmaceutical quality.

22.13 Hydrogen Peroxide Can Play Opposite Redox Roles

Hydrogen peroxide commonly acts as an oxidizing antimicrobial because it can oxidize susceptible biological components. In its acidic permanganate assay, however, it acts as a reducing agent. The peroxide is oxidized to oxygen while permanganate is reduced to manganese(II). Redox role is defined relative to the reaction partner, not permanently assigned by the substance’s pharmaceutical classification.

The balanced assay uses two permanganate ions for five peroxide molecules. One millilitre of 0.0200 mol/L permanganate therefore represents 0.0500 mmol peroxide. Multiplication by 34.014 mg/mmol produces the 1.7007 mg/mL factor. The factor’s origin remains visible when derived from the reaction.

Peroxide decomposition also produces oxygen, but it is a different chemical event from the complete permanganate titration. Light, heat and catalytic contamination can lower the amount of peroxide remaining before analysis. Bubbling does not independently measure the original concentration or establish antimicrobial performance.

The warm conditions used in oxalate standardization of permanganate should not be transferred automatically to peroxide assay. Unnecessary heating can change the analyte through decomposition. A good analytical answer names the actual sample reaction, distinguishes it from reagent standardization, and explains why sample stability and the selected acid medium must be controlled.

22.14 Deriving Peroxide Volume Strength

Volume strength expresses the volume of oxygen obtainable from one volume of peroxide solution under stated gas reference conditions. It differs from mass percentage, mass-per-volume percentage and chemical molarity. The conversion follows decomposition stoichiometry together with gas molar volume.

Two peroxide moles produce one oxygen mole. At the reference conditions used in these notes, one ideal gas mole occupies approximately 22.414 litres. One peroxide mole therefore supplies about 11.207 litres oxygen. Combining this with peroxide molar mass gives the approximate relation between percent w/v and volume strength.

A 3.0% w/v solution contains 3.0 g in 100 mL. Its peroxide amount is about 0.0882 mol, yielding about 0.0441 mol oxygen. This corresponds to roughly 0.988 litres oxygen from 0.100 litres solution, or approximately 9.9-volume. The conventional near-10-volume description follows from this calculation.

The result depends on gas reference conditions. An equation derived using one temperature and pressure cannot be described as exact for every gas collection condition. Also, oxygen evolved during handling may reflect partial decomposition rather than the complete theoretical amount. In an examination, state the decomposition equation, gas assumptions, concentration basis and final ratio rather than treating volume strength as another name for percentage.

22.15 Available Chlorine Is an Oxidizing-Capacity Basis

Chlorinated lime contains different chlorine-containing species. Some contribute active oxidizing capacity, while chloride is not an equivalent disinfecting oxidant. Available chlorine expresses the oxidizing capacity as an equivalent mass of Cl₂. It is not simply the sum of all chlorine-atom masses in the material.

The iodometric assay translates active oxidant into liberated iodine. Iodine is then measured by thiosulfate. Combining the reactions gives two thiosulfate moles per mole of Cl₂ equivalent. The factor therefore depends on thiosulfate concentration and the molar mass assigned to Cl₂ equivalent, rather than on a single assumed pure formula for bleaching powder.

Aging and storage can reduce available chlorine even when the powder looks similar. A visual inspection cannot replace assay. Representative sampling and a defined sample preparation are also important because an incompletely mixed powder or dispersion may not represent the material’s overall oxidizing content.

Acidification in the analytical method is a controlled laboratory step used to generate measurable iodine under specified conditions. It must not be confused with casual mixing of chlorine-releasing household products. The academic distinction is important: an assay deliberately establishes a defined reaction in suitable containment, whereas inappropriate product mixing can generate hazardous gases without an analytical purpose or controlled conditions.

22.16 Dissolved Iodine, Triiodide and Iodophors

Iodine has limited solubility in water, but iodide supports formation of triiodide and related polyiodide species. This equilibrium increases the amount that can be held in aqueous solution. It does not mean that potassium iodide and iodine are the same substance or that their masses have identical antimicrobial meaning.

An aqueous iodine–iodide preparation, an alcohol-containing tincture and a povidone-iodine preparation have different formulation systems. A labelled percentage of the carrier complex is not automatically the same percentage of available iodine. Total content, available content and free reactive iodine should be interpreted according to the product’s specification.

A carrier system can hold and release iodine through equilibrium. Its role differs from merely adding more iodine mass to the bottle. Organic load, pH and contact conditions influence the reactive fraction available at the target. Therefore, a total iodine assay and a performance assessment answer different questions.

For direct iodine measurement with thiosulfate, the ratio remains one iodine mole to two thiosulfate moles under the stated reaction. Matrix-specific sample treatment may still be necessary. An iodophor cannot automatically be assayed by ignoring its carrier and solvent. A complete answer names the preparation, explains dissolution or release, states the reporting basis, and connects the endpoint with disappearance of low-concentration starch-iodine colour.

22.17 Nuclear Change Is Different From Chemical Change

A chemical reaction changes bonding, molecular arrangement or oxidation state while ordinarily leaving the nucleus unchanged. Radioactive decay changes an unstable nucleus. Dissolving a radiopharmaceutical, binding its radionuclide to a ligand or washing a contaminated surface does not ordinarily stop nuclear decay. Those processes change chemical form or location.

Isotopes have the same proton number but different mass numbers because their neutron counts differ. A radionuclide is an unstable nuclide, and a radiopharmaceutical is a medicinal preparation containing a radionuclide. The preparation therefore requires both nuclear identity and pharmaceutical chemical identity.

Radiation labels also need precision. Alpha particles are helium nuclei, beta-minus particles are electrons from nuclear transformation, and gamma radiation consists of photons. An emitted electron should not be described as an alpha particle simply because both can ionize matter. Emission type influences range, detection, shielding and internal-distribution concerns.

A metastable state is an excited nuclear state with a measurable lifetime. The m in technetium-99m identifies that state. Its transformation to technetium-99 changes nuclear excitation and produces useful emissions, but the daughter is not thereby guaranteed stable. These distinctions prevent an imaging radionuclide’s short half-life from being mistaken for instantaneous disappearance of all radioactive material.

22.18 Reading an Activity Label Correctly

Activity measures disintegrations per second. A becquerel is one such event per second, and megabecquerels and gigabecquerels are multiples of that unit. Activity is not chemical molarity, solution volume, absorbed dose or photon energy. A complete label connects activity with radionuclide and reference time.

A preparation containing 600 MBq in 5.00 mL has an activity concentration of 120 MBq/mL at that time, assuming uniform mixing. If its activity halves while volume remains unchanged, concentration becomes 60 MBq/mL. The liquid need not visibly change during that process.

Absorbed dose concerns energy deposited per unit mass and uses gray. Converting source activity to absorbed dose requires additional information about emitted energy, elapsed exposure, geometry, distribution and absorption. There is no universal rule that one megabecquerel equals one particular milligray for every radionuclide and situation.

The activity at calibration time also differs from activity at a later use time. Short-lived radionuclides can change substantially over a few hours. Records must therefore identify a time rather than present an isolated number. For educational calculations, establish whether the question asks total source activity, activity per millilitre, amount remaining in a biological compartment or absorbed energy. The quantity requested determines the appropriate equation.

22.19 Physical, Biological and Effective Half-Lives

Physical half-life describes loss of radioactive nuclei through decay. Biological half-life describes removal from a specified biological compartment by physiological processes. Effective half-life combines both losses under a suitable independent first-order model. These quantities answer different questions even when all are expressed in hours or days.

The effective loss rate is the sum of the two rate constants. Because each rate constant is proportional to the reciprocal half-life, the relationship becomes 1/Teff = 1/Tphys + 1/Tbio. Consequently, effective half-life is shorter than either finite component. Averaging the two half-lives would describe a different mathematical operation and gives an incorrect result.

For physical half-life of 8 days and biological half-life of 12 days, the combined value is 4.8 days. The calculation does not establish that every patient or organ clears iodine with a 12-day biological half-life. It is an illustration of the model using supplied numbers.

Real biological distribution can involve multiple compartments and rates. A source remaining in a vial follows physical decay without patient elimination. Material in a patient can undergo both decay and redistribution or excretion. Before selecting a half-life equation, identify the system boundary and which loss mechanisms the problem includes. This prevents a biological assumption from being inserted into a simple source-decay question.

22.20 Chemical Form Connects a Radionuclide to Its Target

A radionuclide’s emission is a nuclear property, while its distribution is strongly influenced by chemical form and biological handling. Radioactive iodide can be taken up by thyroid tissue through iodide transport mechanisms. A technetium-labelled compound can have a distribution different from free pertechnetate. The radionuclide name alone therefore does not specify the target organ.

This distinction is central to radiochemical purity. A preparation can contain the intended radionuclide but have activity in an unintended chemical form. The detector may still measure the expected overall activity, while localization is no longer appropriate. Radionuclidic identity and radiochemical identity are separate quality questions.

Diagnostic selection considers whether emitted radiation can provide useful external detection during an appropriate time window. Therapeutic selection additionally considers local energy deposition, particle range, targeting and residence time. The same isotope can support different applications depending on preparation and clinical purpose, but those uses are not interchangeable without a defined product and specialist protocol.

The four prescribed isotopes illustrate the range. Iodine-131 connects iodine-avid tissue with beta and gamma emissions. Technetium-99m supports many imaging preparations. Cobalt-60 commonly functions as a sealed source in engineered equipment. Phosphorus-32 is principally a beta emitter used in appropriate tracer and specialist settings. Their chemical forms, source types and exposure controls must remain distinct.

22.21 Matching Shielding and Instruments to Radiation

Shielding is selected for emission type and energy rather than applied as one universal material. A low atomic-number material is useful as an initial barrier for energetic beta particles because it can limit beta exposure while reducing bremsstrahlung production compared with an unsuitable dense first barrier. Secondary photon shielding may also be necessary. Gamma sources require an appropriately engineered attenuation arrangement.

No simple diagram should imply that every photon disappears behind a sheet. Attenuation depends on energy, thickness, geometry and scattering. Shielding complements time and distance; it does not replace contamination control for unsealed preparations. A shielded vial can still spread contamination if material escapes its container.

Measurement instruments also have different roles. A dose calibrator estimates activity for a specified radionuclide and geometry. A gamma camera forms distribution images. A survey meter measures a radiation field or detects contamination according to its detector and calibration. A personal dosimeter records relevant exposure over its intended monitoring period.

A reading is meaningful only when the instrument responds appropriately to the source. Energy response, sensitivity, geometry, calibration and possible saturation influence interpretation. Calling every radiation instrument a Geiger counter obscures these differences. An examination answer should connect the quantity being measured with the instrument and explain why a different device may be required for another measurement task.

22.22 Distinguishing Decay Arithmetic From Authorized Release

After ten physical half-lives, approximately one part in 1024 of the original activity remains. That is a statement of exponential decay, not an automatic disposal authorization. The remaining absolute activity depends on the starting amount, and the waste may contain other radionuclides or additional hazards.

Short-lived material can be eligible for decay storage only within an authorized system. Characterization, monitoring, records and release criteria remain necessary. A container that has stood for a long time cannot be declared ordinary waste from appearance alone. Chemical toxicity, biological hazards and sharps remain relevant even when activity has decreased substantially.

Sealed and unsealed sources also require different management. A disused cobalt-60 source remains a controlled source and should follow an authorized return or transfer route. Opening it or discarding it in ordinary refuse is not a waste-minimization technique. Unsealed liquids need compatible containment and a permitted route rather than casual discharge.

The educational principle is to separate a physical calculation from an institutional decision. A half-life calculation predicts activity under specified assumptions. Authorized waste management additionally establishes identity, remaining hazards, measurement evidence and compliance with applicable conditions. This distinction explains why records, trained personnel, inventory and radiation safety responsibilities are part of the syllabus rather than optional additions to decay equations.

23. Additional Worked Numerical Practice

These Pharmaceutical Inorganic and Analytical Chemistry Unit 4 Notes use a common calculation approach: identify the measured substance, balance the reaction, calculate amount, convert to the required reporting basis, and then apply justified corrections. The examples below extend the supplied unit with explicit practice assumptions.

Example 23.1: Bicarbonate Mass From an Acid Titre

A sodium bicarbonate sample consumes 25.00 mL of 0.2000 mol/L hydrochloric acid. Assume complete reaction and no blank or aliquot correction. Acid amount is 25.00 × 0.2000 = 5.000 mmol. The bicarbonate-to-acid ratio is one-to-one, so the sample contains 5.000 mmol bicarbonate. Multiplication by 84.01 mg/mmol gives 420.05 mg NaHCO₃. This mass is the chemically represented bicarbonate amount, not necessarily the complete weighed sample mass. To calculate purity, divide it by the original sample mass expressed in the same units. A carbonate factor would be inappropriate because carbonate has a different full-neutralization ratio.

Example 23.2: Bicarbonate Assay With Blank and Standardization Factor

A 0.5000 g sample gives a titre of 29.60 mL. The applicable direct blank is 0.10 mL. Nominal acid concentration is 0.2000 mol/L, but its standardization factor is 0.9950. Corrected volume is 29.50 mL, and actual acid concentration is 0.1990 mol/L. Bicarbonate amount is 29.50 × 0.1990 = 5.8705 mmol. Mass found is 5.8705 × 84.01 = 493.18 mg approximately. Therefore purity ≈ 98.64% w/w. The factor has already entered through actual concentration. Applying 0.9950 again would count the strength correction twice and underestimate the result.

Example 23.3: An Aliquot in a Bicarbonate Assay

A 1.000 g sample is made to 100.0 mL. A 20.00 mL aliquot consumes 11.80 mL of 0.2000 mol/L HCl. The aliquot bicarbonate mass is 11.80 × 16.802 = 198.2636 mg. The aliquot represents one-fifth of the sample preparation, so total represented bicarbonate is 198.2636 × 5 = 991.318 mg. Percentage is 991.318/1000 × 100, giving 99.13% w/w approximately. Dividing the aliquot mass directly by the full sample mass would give a fivefold underestimate. The dilution factor changes the represented sample quantity, not the reaction coefficient.

Example 23.4: Theoretical Acid-Neutralizing Capacity

Calculate the theoretical capacity of 0.5000 g pure sodium bicarbonate. Amount is 0.5000/84.01 = 0.005952 mol approximately, equal to 5.952 mmol. One bicarbonate consumes one hydrogen-ion equivalent, so capacity is 5.952 mEq H⁺. For 0.5000 g pure magnesium hydroxide, amount is about 8.573 mmol and each millimole consumes two milliequivalents. Its theoretical capacity is therefore approximately 17.15 mEq H⁺. This comparison concerns pure substances and complete reaction. It does not establish their relative neutralization rates or suitability as formulated medicines under every condition.

Example 23.5: Mixture Capacity From Defined Pure Components

An educational mixture contains 0.2500 g pure NaHCO₃ and 0.1000 g pure Mg(OH)₂. Assume complete independent reaction with acid. Bicarbonate capacity is 0.2500/84.01 × 1000 = 2.976 mEq approximately. Magnesium hydroxide capacity is 0.1000/58.32 × 2 × 1000 = 3.429 mEq approximately. Total theoretical capacity is 6.405 mEq H⁺. The calculation adds acid equivalents, not the two compound mole amounts without weighting. A real formulation would also require the defined ANC test because dispersion, reaction rate and the selected endpoint can affect measured performance.

Example 23.6: Net EDTA in an Aluminium Assay

An aliquot receives 30.00 mL of 0.05000 mol/L EDTA. Remaining ligand requires 8.00 mL of a 0.05000 mol/L standard metal in a one-to-one back reaction. Added ligand is 1.500 mmol and residual ligand is 0.4000 mmol. Aluminium amount is therefore 1.100 mmol. As Al₂O₃ equivalent, this becomes 0.5500 mmol oxide, giving 0.5500 × 101.96 = 56.078 mg Al₂O₃ equivalent. As Al(OH)₃ equivalent, it represents approximately 1.100 × 78.00 = 85.80 mg. The result must identify which reporting basis the question requests.

Example 23.7: Aluminium Back-Titration With Unequal Strengths

An aliquot receives 40.00 mL EDTA at 0.04990 mol/L. Residual ligand requires 12.00 mL of a 0.05020 mol/L one-to-one metal back-titrant. Added EDTA is 1.9960 mmol. Remaining EDTA is 0.6024 mmol. Thus aluminium amount is 1.3936 mmol. Oxide equivalent is 1.3936/2 × 101.96 = 71.05 mg Al₂O₃ approximately. Subtracting the two volumes first and multiplying by one concentration would ignore the different actual strengths. Each reaction amount must be established separately before calculating the ligand difference and reporting-species conversion.

Example 23.8: Applying an Aluminium Assay Aliquot Factor

A sample preparation is made to 250.0 mL, and a 25.00 mL aliquot gives 56.078 mg Al₂O₃ equivalent. The aliquot fraction is 25.00/250.0 = 0.1000. Therefore the complete preparation contains 560.78 mg Al₂O₃ equivalent. If the original wet-gel portion weighed 10.000 g, oxide-equivalent content is 0.56078/10.000 × 100 = 5.608% w/w approximately. This is not automatically the percentage of anhydrous Al(OH)₃. Converting the reporting species would require the corresponding aluminium-based factor, while the gel’s water remains part of the original sample denominator.

Example 23.9: Dilute Hydrochloric Acid Assay

An aliquot representing 1.000 mL original dilute HCl consumes 20.00 mL of 0.1000 mol/L NaOH. The neutralization ratio is one-to-one. HCl amount is 2.000 mmol, and mass is 2.000 × 36.46 = 72.92 mg HCl in the represented original millilitre. This corresponds to 7.292 g per 100 mL, or 7.292% w/v, under the stated representation. A percentage by mass cannot be obtained from this information alone without a suitable mass basis. The example illustrates unit conversion rather than prescribing a universal pharmaceutical HCl strength.

Example 23.10: Boric Acid in a Defined Polyol-Assisted Assay

A specified polyol-assisted boric acid method uses a one-to-one equivalence scheme. Sample titre is 15.20 mL of 0.1000 mol/L NaOH and the applicable polyol blank is 0.20 mL. Corrected titre is 15.00 mL. Boric acid amount is 1.500 mmol. Multiplication by 61.83 mg/mmol gives 92.745 mg H₃BO₃. For an original 0.1000 g sample, the calculated percentage is 92.745% w/w. The calculation is valid for the stated modified assay. It does not establish a sharp direct endpoint for unmodified aqueous boric acid.

Example 23.11: Peroxide Mass From Permanganate

A suitable peroxide aliquot consumes 12.00 mL of 0.02000 mol/L permanganate in the specified acidic assay. Titrant amount is 0.2400 mmol. The balanced reaction gives 2.5 peroxide moles per permanganate mole. Therefore peroxide amount is 0.6000 mmol. Mass is 0.6000 × 34.014 = 20.4084 mg H₂O₂. The direct factor route gives the same result: 12.00 × 1.7007 mg/mL. The factor must be adjusted if actual permanganate concentration differs. The observation of oxygen bubbles does not replace measurement of the complete corrected titre.

Example 23.12: Peroxide Percentage With a Defined Dilution

Ten millilitres of original peroxide solution are diluted to 100.0 mL. A 10.00 mL diluted aliquot therefore represents 1.000 mL original solution. It consumes 17.60 mL of 0.02000 mol/L KMnO₄. Peroxide mass is 17.60 × 1.7007 = 29.93232 mg in the original represented millilitre. Scaling to 100 mL gives 2.993232 g. Therefore strength ≈ 2.993% w/v. There is no additional tenfold multiplication after establishing the original volume represented by the aliquot. Applying the dilution twice would make the final strength ten times too large.

Example 23.13: Peroxide With a Required Blank

Suppose a validated peroxide assay requires subtraction of a matching blank. Sample titre is 18.10 mL and blank is 0.10 mL of 0.02000 mol/L KMnO₄. Corrected titre is 18.00 mL. Mass represented is 18.00 × 1.7007 = 30.6126 mg H₂O₂. If this corresponds to 2.000 mL original sample, concentration is 15.3063 mg/mL. Scaling gives 1.531% w/v approximately. The original represented volume is essential. A mass calculated correctly from titration is not yet a percentage until it is connected to the appropriate sample quantity.

Example 23.14: Percentage to Volume Strength

Using the stated reference gas conditions, estimate volume strength of 2.50% w/v peroxide. The convenient relation gives 3.29 × 2.50 = 8.225-volume, approximately 8.23-volume. This means that complete decomposition of one volume of solution yields about 8.23 volumes oxygen at those reference conditions. It does not mean 8.23% peroxide or that every stored bottle already contains that oxygen volume as gas. The result follows the hypothetical complete decomposition and gas measurement assumptions. A different gas temperature or pressure changes the precise numerical conversion.

Example 23.15: Volume Strength to Percentage

A peroxide solution is described as approximately 10-volume at the same reference conditions. Rearranging gives percent w/v ≈ 10/3.29, or 3.04% w/v approximately. The conventional relationship is approximate, so the result should not be reported with unjustified analytical precision. An actual content assay determines the preparation’s current peroxide concentration. Storage-related decomposition can change content after manufacture. The conversion therefore interprets a strength description; it does not replace a stability assessment or standardized assay of a particular sample.

Example 23.16: Available Chlorine in a Directly Represented Sample

An aliquot representing 0.1000 g chlorinated lime consumes 9.20 mL of 0.1000 mol/L thiosulfate in the specified iodometric assay. Each millilitre represents 3.545 mg Cl₂ equivalent. Available chlorine in the represented sample is 9.20 × 3.545 = 32.614 mg. Percentage is 32.614/100.0 × 100 = 32.61% w/w. The percentage refers to available chlorine, not total chlorine atoms or purity of a single assumed CaOCl₂ molecule. The powder’s actual composition and oxidizing content are established through the stated assay basis.

Example 23.17: Available Chlorine With an Aliquot and Blank

A 1.000 g sample is prepared to 250.0 mL. A 25.00 mL aliquot consumes 9.80 mL thiosulfate; the appropriate blank is 0.10 mL. Titrant concentration is 0.1000 mol/L. Corrected titre is 9.70 mL, giving 9.70 × 3.545 = 34.3865 mg Cl₂ equivalent in the aliquot. Multiply by ten for the complete preparation: 343.865 mg. Therefore available chlorine ≈ 34.39% w/w. The blank, concentration and aliquot basis must all correspond to the actual reaction scheme. The aliquot mass cannot be compared directly with the complete one-gram sample without scaling.

Example 23.18: Iodine Content From Thiosulfate

A suitably prepared iodine sample consumes 15.00 mL of 0.1000 mol/L sodium thiosulfate. Thiosulfate amount is 1.500 mmol. Iodine amount is half that value, 0.7500 mmol. Using 253.81 mg/mmol gives 190.36 mg I₂ approximately. The source’s rounded factor of 12.690 mg/mL produces 190.35 mg, consistent at its stated precision. If the sample was an iodophor, this result must be interpreted using the method’s extraction and available-content basis. It is not automatically the total mass of povidone-iodine complex present.

Example 23.19: Why Halogen Factors Differ

Compare 10.00 mL of 0.1000 mol/L thiosulfate in two stated assays. As available chlorine, the represented amount is 10.00 × 3.545 = 35.45 mg Cl₂ equivalent. As iodine, it is 10.00 × 12.690 = 126.90 mg I₂. Both reactions use two thiosulfate moles per diatomic-halogen mole, but Cl₂ and I₂ have different molar masses. Identical reagent volume and reaction coefficient do not imply identical mass factors. The reporting species must always accompany a quoted milligram-per-millilitre factor.

Example 23.20: Three Complete Physical Half-Lives

A source has activity 640 MBq at its reference time. After three complete physical half-lives, remaining fraction is (1/2)³ = 1/8. Therefore activity = 80 MBq. The amount lost is 560 MBq, but that loss did not occur as three equal absolute decrements. The successive activities are 640, 320, 160 and 80 MBq. Each interval removes half of what remains. This distinction explains why subtracting a fixed activity amount per hour does not reproduce exponential decay over multiple intervals.

Example 23.21: A Fractional Technetium Half-Life

A collected Tc-99m preparation contains 800 MBq at 09:00. Using a six-hour physical half-life, three hours is half a half-life. Remaining fraction is 2^(−3/6) = 1/√2, approximately 0.7071. Thus activity at 12:00 ≈ 565.7 MBq. It is not 600 MBq from a linear half-of-a-half subtraction. This example assumes isolated collected material without replenishment from a parent generator. It also excludes biological elimination because the system being calculated is a preparation outside the patient.

Example 23.22: Activity Concentration at a Later Time

A uniformly mixed Tc-99m preparation contains 1200 MBq in 6.00 mL at 08:00. Initial concentration is 200 MBq/mL. At 14:00, one six-hour half-life has elapsed, so total activity is 600 MBq. If volume remains 6.00 mL, concentration is 100 MBq/mL. The numerical change is caused by decay rather than dilution. If volume also changed, both activity and volume would be required for the new concentration. A total activity value cannot be substituted directly for MBq per millilitre.

Example 23.23: Reversing a Decay Calculation

An isolated preparation has 150 MBq after two physical half-lives. What was its activity at the earlier reference time? After two half-lives, one-quarter remains. Therefore initial activity was 150 × 4 = 600 MBq. This is a reverse calculation, so multiplication replaces the forward halving operation. Write the earlier and later times clearly to avoid reversing the direction. The example establishes source activity under a supplied model; it does not define a prescribed patient activity or an authorization to handle the calculated source.

Example 23.24: Effective Half-Life From Unequal Components

For a mathematical biological-compartment model, physical half-life is 8.0 days and biological half-life is 12.0 days. Effective half-life is (8.0 × 12.0)/(8.0 + 12.0) = 4.8 days. After 4.8 days, the model predicts half the original compartment activity remains through the combined processes. If the question asked only about a sealed vial, biological removal would not be included. State which system is being modelled. The numerical biological value supplied here is illustrative rather than a universal organ-clearance value for a specific radiopharmaceutical.

Example 23.25: Equal Physical and Biological Half-Lives

Suppose both physical and biological half-lives are 10 days. The reciprocal relationship gives 1/Teff = 1/10 + 1/10 = 1/5. Hence effective half-life = 5 days. The result is not 10 days, because two independent loss mechanisms operate together. It is not zero either, because both processes are gradual first-order losses. Checking that effective half-life is shorter than either finite component provides a quick mathematical reasonableness test. This check can identify an accidental arithmetic mean or an inverted reciprocal calculation.

Example 23.26: Unit Consistency in Half-Life Calculations

A six-hour half-life can also be written as 360 minutes. For a 90-minute interval, the correct exponent is −90/360 = −0.25. A preparation initially at 400 MBq therefore retains 400 × 2^(−0.25), approximately 336.4 MBq. Using 90/6 would treat minutes as hours and produce a grossly incorrect value. The ratio in an exponent must be dimensionless. Convert time and half-life to the same unit before calculation, then preserve a sensible number of figures in the final activity.

Example 23.27: Activity Remaining After Ten Half-Lives

For an initial activity of 1024 MBq, ten physical half-lives leave 1024/1024 = 1 MBq. The remaining fraction is small, but the absolute remaining activity is still one million disintegrations per second. This result illustrates why a fraction alone cannot determine whether a source can be released or discarded. Identification, other radionuclides, additional hazards, measurement evidence and authorization remain relevant. The calculation is a decay prediction, not a disposal instruction. The same fraction applied to another initial activity would give a different remaining absolute activity.

Example 23.28: An Idealized Distance Comparison

Under the stated approximate point-source inverse-square model, compare intensity at 0.50 m with intensity at 1.50 m. The second distance is three times the first, so intensity ratio is (0.50/1.50)² = 1/9. This is a relative model result, not an absolute worker-dose estimate. Extended sources, scattering, attenuation and changed geometry can invalidate the simple relationship. A real radiation measurement requires suitable instrumentation and conditions. The academic calculation shows why distance is useful while preserving the model’s limits.

24. Examination Answer Development

24.1 How to Write a Complete Sodium Bicarbonate Answer

Begin with formula, synonym and physical properties. Identify it as sodium hydrogen carbonate, a white crystalline material with a mildly alkaline solution. Then explain preparation through controlled bicarbonate formation from carbonate and carbon dioxide, while distinguishing that reaction from pharmaceutical purification and manufacturing controls.

Give the acid reaction and connect it to rapid antacid action, gas evolution and limitations. The carbon dioxide product explains belching and distension. Absorbable sodium and bicarbonate explain why local neutralization can be accompanied by systemic electrolyte and alkali effects. These are chemical consequences, not unrelated memorized adverse-effect labels.

For assay, state direct acidimetry with standardized HCl, the method-defined endpoint and one-to-one stoichiometry. Derive the factor at the stated acid concentration. Include a calculation using corrected volume and any aliquot factor. End with identity, relevant impurities, moisture and heat protection. This structure covers preparation, properties, mechanism, assay, uses and storage without presenting the compound as universally appropriate for every gastrointestinal complaint.

24.2 How to Write a Complete Aluminium Hydroxide Gel Answer

Identify the gel as a hydrated amorphous dispersion and explain why wet-gel mass differs from pure dry hydroxide mass. Describe controlled precipitation, removal of soluble salts and redispersion. Connect pH control with amphoterism and the possibility of redissolution in excess alkali.

Explain slow local acid neutralization without bicarbonate-like carbon dioxide evolution. Include constipation, phosphate binding and accumulation considerations as limitations stated in the unit. Distinguish content from functional acid-neutralization performance, since physical ageing and dispersion can affect reaction.

For assay, outline appropriate sample dissolution, a known EDTA excess, sufficient complexation and residual-ligand back-titration under the selected conditions. Calculate net EDTA amount before converting aluminium into the requested equivalent form. Explain the factor of two when reporting Al₂O₃. Finish with aliquot correction and suitable quality and storage controls. An answer that gives only Al(OH)₃ + 3HCl misses both the gel’s pharmaceutical nature and the analytical reporting basis.

24.3 How to Compare Hydrogen Peroxide and Chlorinated Lime

Organize the comparison by identity, active chemistry, preparation principle, stability, assay and reporting basis. Hydrogen peroxide is an aqueous preparation of a defined peroxide molecule. Chlorinated lime is a variable chlorine-containing mixture for which a simplified formula does not describe every commercial material completely.

Peroxide undergoes decomposition to oxygen and water and is assayed here through acidic permanganometry. Chlorinated lime supplies hypochlorous-acid/hypochlorite chemistry and is assayed for available chlorine through iodine liberation followed by thiosulfate titration. State the balanced relationships and different milligram factors.

Both can lose useful active content during unsuitable storage, and both react with organic matter. Their intended application and tissue compatibility are formulation-dependent. Avoid saying that both merely release nascent oxygen or that equal percentages give equal antimicrobial performance. A useful comparison explains why the active species, content basis and assay chemistry differ while highlighting the shared need for suitable contact conditions, stability control and validated use.

24.4 How to Compare the Four Prescribed Radioisotopes

Use separate columns for radionuclide, approximate physical half-life, principal emission information, source or chemical form, major role and quality or handling distinction. This prevents half-life values from becoming disconnected from medical purpose. It also distinguishes a sealed cobalt source from an unsealed diagnostic or therapeutic preparation.

For I-131, connect radioactive iodide with iodine-avid thyroid tissue and beta/gamma emissions. For Tc-99m, explain metastability, approximately six-hour decay and the role of chemical labelling in different imaging distributions. For Co-60, identify energetic gamma emissions and engineered sealed-source applications. For P-32, identify principally beta-minus emission and appropriate tracer or specialist contexts.

Do not describe all four as routine injectable medicines, all gamma emitters, or all materials suitable for the same shield. Add the principle that nuclear properties and chemical targeting must be considered together. Quality control, calibration time and authorized handling complete the comparison. Patient selection and administration details remain within specialist protocols rather than being inferred from a classroom isotope table.

25. Frequently Asked Questions and Short-Answer Revision

Why Is the Fastest Antacid Not Automatically the Best One?

Fast neutralization is one useful property, but an ideal antacid also needs appropriate duration, local action, tolerability, stability and predictable quality. Sodium bicarbonate reacts rapidly but evolves gas and introduces sodium and absorbed alkali. A slower hydroxide suspension can have a different local profile. Formulation and exposure matter alongside the balanced equation. An academic comparison should identify complementary advantages and limitations rather than rank every product by reaction speed alone. Measured acid-neutralizing performance under defined conditions supports a more meaningful comparison than appearance or a simple list of ingredients.

Why Must Sodium Phosphate Be Named More Precisely?

The term can refer to salts with different degrees of neutralization and different hydrates. Monobasic NaH₂PO₄ and dibasic Na₂HPO₄ differ in acid-base behaviour. A hydrate differs in formula mass from its anhydrous salt. Pharmaceutical phosphate preparations also have formulation-specific purposes. Consequently, an acidic buffer, a saline laxative preparation and an industrial phosphate material cannot be exchanged merely because all contain sodium and phosphate. State exact formula and hydrate before calculating amount, acidity, osmotic contribution or pharmaceutical content.

Does Aluminium Hydroxide’s Low Solubility Prevent Antacid Action?

No. It can react with gastric acid even though it is poorly soluble in plain water. Hydrogen ions are consumed at the solid–liquid interface, and the pharmaceutical dispersion supports contact. However, rate and extent depend on particle properties, mixing and formulation. This is why pure formula content alone does not establish complete performance. The gel’s hydration and physical condition also matter. Describe acid reaction and material behaviour together rather than treating water solubility as an all-or-nothing test of antacid usefulness.

Is Boric Acid Triprotic Because Its Formula Contains Three Hydrogens?

Not in the conventional aqueous sense suggested by that shortcut. Boric acid acts principally as a Lewis acid through hydroxide acceptance, and its ordinary aqueous acidity is weak. Polyol-assisted complexation changes the analytical response and supports a suitable alkalimetric assay. The method’s one-to-one factor belongs to that defined scheme. Counting hydrogen atoms in a formula is not a sufficient basis for assigning titration equivalents. Explain the actual reaction and endpoint conditions before selecting an equivalent mass or assay factor.

Why Is Bubbling Not Proof of Peroxide Disinfection?

Bubbling shows oxygen evolution, which can be accelerated by catalase or other catalysts. It does not independently establish concentration, contact time, microbial susceptibility or complete target exposure. Organic material and tissue constituents can consume peroxide while bubbles remain visible. A formulation’s suitability depends on its intended use and validated performance. For analysis, measure content through the prescribed reaction and corrected titre. For an examination explanation, connect effervescence with decomposition while keeping antimicrobial oxidation and product effectiveness as related but distinct questions.

Why Does Peroxide Act as a Reducing Agent During Its Assay?

Redox role depends on the reaction partner. Peroxide commonly oxidizes susceptible microbial components, but acidic permanganate is the oxidant in the specified assay. Peroxide is converted to oxygen while manganese(VII) is reduced to manganese(II). The balanced reaction therefore assigns peroxide the reducing role. This does not contradict its antimicrobial classification. Always identify what is oxidized and reduced in the actual reaction rather than assigning an unchanging role from the substance’s name or common use.

What Is the Difference Between Available Chlorine and Total Chlorine?

Available chlorine expresses oxidizing capacity as Cl₂ equivalent. Total chlorine includes chlorine present in different chemical forms, including chloride that does not supply equivalent disinfecting oxidation. A bleaching-powder mixture can therefore contain chlorine atoms without all of them contributing to the available-chlorine assay. Aging also changes active content. The iodometric assay measures the defined oxidizing contribution, not a universal percentage inferred from an assumed pure molecule. State the available-content basis whenever reporting the result.

Does a Percentage of Povidone-Iodine Equal the Same Percentage of Free Iodine?

No. The labelled carrier-complex percentage and available-iodine percentage are different quantities. Equilibrium between bound and released forms also affects free reactive iodine. Interpret the product using its stated specification and assay basis. An iodophor’s identity does not justify treating its entire mass as I₂. The same attention is needed when comparing aqueous iodine–iodide solutions and alcohol-containing preparations: solvent, carrier and active-content descriptions identify different parts of the formulation.

Does a Short Physical Half-Life Mean Immediate Harmlessness?

No. Short half-life means rapid fractional decay, but remaining activity depends on elapsed time and initial activity. Daughter products and nonradioactive chemical or biological hazards may also matter. Tc-99m’s transition gives Tc-99, which is long-lived and radioactive. Authorized storage, monitoring and waste decisions therefore require more than a single half-life value. A decay calculation supports understanding of activity change; it does not by itself establish that material is safe for an unrestricted use or disposal route.

Why Is Radiochemical Purity Different From Radionuclidic Purity?

Radionuclidic purity asks which radionuclides contribute the activity. Radiochemical purity asks which chemical forms contain that activity. A sample can contain the intended isotope yet have activity in an unintended compound, changing biological distribution. Chemical purity separately concerns nonradioactive contaminants. These controls are complementary. Measuring activity does not automatically establish any of them. A complete radiopharmaceutical description needs nuclear identity, chemical form, activity at reference time and relevant pharmaceutical quality rather than only the expected isotope name.

Why Is a Dose Calibrator Not the Same as a Gamma Camera?

A dose calibrator measures sample activity under defined radionuclide settings and geometry. A gamma camera forms images related to the spatial distribution of emitted photons. They answer different measurement questions. A survey instrument or wipe test has another purpose, such as assessing radiation fields or removable contamination. Instrument choice depends on the quantity, radiation type, energy and required calibration. Do not call every radiation detector an activity calibrator or assume that an image establishes the exact activity in a vial.

Why Should a Radioactive Activity Always Have a Reference Time?

Activity decreases continuously through decay. A number measured or calibrated earlier may not describe the preparation at a later examination time. This is particularly important for short-lived radionuclides, where a few hours can change activity substantially. The reference time allows a decay calculation and a consistent record. Activity concentration also requires volume at the relevant time. Without those details, identical numbers on two labels may refer to different actual source conditions. Time is therefore part of the measurement’s meaning rather than an optional administrative note.

Why Does Effective Half-Life Become Shorter Than Either Component?

Under the stated model, physical decay and biological removal independently reduce activity in the compartment. Their rate constants add, so total loss is faster than either mechanism alone. Since half-life is inversely related to rate constant, the effective value becomes shorter. It is not an arithmetic mean. This conclusion assumes the specified first-order model and compartment. It should not be applied blindly to complicated biological redistribution or to a source outside the patient where physiological removal is absent.

Is Ten Half-Lives an Automatic Disposal Rule?

No. Ten half-lives gives a remaining fraction of about 1/1024. It does not identify the absolute activity, additional radionuclides, chemical hazards or applicable authorization. Decay storage and later release require the facility’s prescribed assessment, monitoring and records. A long-lived contaminant can invalidate a simple short-lived-source calculation. Sealed-source management also follows an authorized route. The examination point is to distinguish exponential arithmetic from a regulated disposal decision supported by characterization and measurement.

How Should a Long Answer Be Organized?

For a compound, use identity and form, preparation principle, properties, mechanism, assay reaction, calculation basis, uses, limitations and storage. For a radioisotope, use nuclear identity, half-life, emissions, chemical form or source type, application, quality control and protection. These Pharmaceutical Inorganic and Analytical Chemistry Unit 4 Notes use that structure to connect facts with reasons. A diagram should support the explanation, while written equations and units make calculations reviewable. Conclude an examination answer by linking precautions to their chemical or radiation basis rather than adding unrelated warnings.

26. Final Concept Map for Revision

Chemical identity comes first. Specify monobasic phosphate, a defined hydrate, an aqueous acid preparation, hydrated gel, variable silicate or iodine formulation. These names determine what a measured mass represents and which reaction can be assumed. An incorrect starting identity can produce a plausible but chemically wrong numerical answer.

Reaction conditions establish the factor. Bicarbonate uses one acid mole, aluminium uses one EDTA ligand per metal with a reporting conversion, peroxide uses the acidic permanganate ratio, and halogen assays use iodine–thiosulfate relationships. The same titrant can represent different analytes through different coefficients and formula masses.

Formulation modifies behaviour. Dispersion, particle size, solvent, carrier, stability and contact influence pharmaceutical action. A theoretical equation explains capacity but does not independently prove product performance. This is the link between inorganic reaction chemistry and pharmaceutical quality.

Measurement quantities stay distinct. Percent w/w, percent w/v, volume strength, available chlorine, activity, activity concentration and absorbed dose are different quantities. State the numerator, denominator and units before comparing numerical values. A correct conversion requires enough information to connect the requested quantities.

Nuclear properties and chemical targeting work together. Emission and physical half-life describe the radionuclide, whereas chemical form and biological handling influence distribution. Effective half-life introduces a defined biological compartment and additional loss process. Purity tests distinguish nuclear, chemical and radiochemical questions.

Protection and release are evidence-based processes. Time, distance, suitable shielding, containment, monitoring and authorized waste control address different exposure pathways and responsibilities. A decay fraction does not replace source identification or measurement. These Pharmaceutical Inorganic and Analytical Chemistry Unit 4 Notes should therefore be revised as a connected set of mechanisms, assays and quality principles rather than a disconnected list of chemical names.

Regulatory Reference

For the institutional radiation-safety framework, consult the AERB nuclear medicine requirements. Applicable authorization, current rules and facility procedures determine operational requirements.

Exclusive Student Alerts

Join AKTU VIP Telegram & WhatsApp Group

Get immediate exam updates, syllabus changes, quantum PDFs, and viva questions.

Have Questions or Want to Discuss?

Join the community conversation or ask your queries in the comments.

View Comments & Discussion →
Home Notes Syllabus PYQs Quantum